Healthcare & Life Sciences — March 26, 2026

Patent Application: Synergistic Stimulation for Cystic Fibrosis Mucus Obstruction

The USPTO has published a new patent application (US20260083698A1) detailing methods for treating mucus obstruction in cystic fibrosis and other disorders. The application, filed on September 19, 2023, describes a combination therapy involving a b-adrenergic agonist or adenylate cyclase activator with a cholinergic agonist.

Patent Application for Inflammatory Condition Treatment Compositions

The USPTO has published a new patent application (US20260083701A1) for compositions and methods related to the treatment of inflammatory conditions. The application details compounds and formulations aimed at managing inflammation and associated symptoms like dryness, itching, and redness.

Patent Application: Inhalation Formulation for Treating IPF Disease

The USPTO has published a patent application (US20260083702A1) detailing an inhalation formulation for treating Idiopathic Pulmonary Fibrosis (IPF) disease. The application describes formulations using specific drugs like apremilast and roflumilast, aiming to improve bioavailability and clinical efficacy compared to oral administration.

USPTO Patent Application for Indoline Derivatives as Serotonergic Agents

The USPTO has published a patent application (US20260083703A1) for indoline derivatives intended for use as serotonergic agents. The application details potential treatments for disorders related to serotonin receptor activation, including psychosis, mental illnesses, and CNS disorders.

Patent Application: Methods Treat/Prevent Protein Aggregation Diseases Using Sulfatase Inhibitor

The USPTO has published a new patent application (US20260083700A1) detailing methods for treating and/or preventing protein-aggregation diseases by administering a sulfatase inhibitor. The application was filed on September 26, 2025, by inventors Manuel J. Muñoz, Ángel M. Carrión, and Mercedes M. Pérez-Jiménez.

Patent Application for Suppressing Reflux-Induced Protein Adducts

The USPTO has published patent application US20260083686A1, filed on November 24, 2025, by Alexander Zaika and Sergey I Dikalov. The application details methods and compounds for suppressing the accumulation of reflux-induced protein adducts.

USPTO Patent Application for Lactation Reduction Compounds

The USPTO has published a patent application (US20260083687A1) for compounds intended for reducing lactation and improving health. The application, filed on April 14, 2023, lists specific disulfide, sulfide, trisulfide, sulfone, thiosulfinate, and thiosulfonate compounds as preferred embodiments. This represents a new patent filing, not a regulatory rule or guidance.

Skin Barrier Film System Patent Application

The USPTO has published a new patent application, US20260083684A1, for a skin barrier film system. The application details a system comprising a film layer, adhesive, impregnated treatment, and a removable layer, designed to accommodate patient physical attributes. The filing date was September 24, 2025.

Method Uses Monoterpene or Sesquiterpene to Permeabilize Blood Brain Barrier

The USPTO has published a patent application detailing a method for permeabilizing the blood-brain barrier using monoterpenes or sesquiterpenes. The application, assigned to the University of Southern California, describes a treatment for central nervous system cancers involving perillyl alcohol and CAR-T cells.

NACA Tablets Inhibit Vision Reduction in Usher Syndrome Patients

The USPTO has published a patent application (US20260083688A1) detailing compositions and methods for treating Usher syndrome associated retinitis pigmentosa using N-acetylcysteine amide (NACA) tablets. The application outlines specific dosages and claims to inhibit vision degradation and protect retinal sensitivity in patients.

Patent Application: Reversing Dexmedetomidine Sedation

The USPTO has published a patent application (US20260083689A1) detailing methods and compositions for reversing dexmedetomidine sedation using dextroamphetamine and/or lisdexamfetamine. The application was filed on October 7, 2025, by inventors Ken Solt, Oluwaseun Johnson-Akeju, and Emery N. Brown.

Patent Application for Dispersible Pharmaceutical Formulations

The USPTO has published patent application US20260083690A1 concerning dispersible pharmaceutical formulations of a specific chemical compound. The application details the composition and potential uses of these formulations.

Patent Application for Psychoactive Medicines Treating Disorders

The USPTO has published patent application US20260083699A1 by Transcend Therapeutics, Inc. The application details psychoactive medicines, including 2C-B and cathinones, for treating psychiatric and neurological conditions. The filing date was December 4, 2025.

Patent Application for Treating Disease with Dichlorphenamide

The USPTO has published a patent application (US20260083692A1) from Strongbridge Dublin Limited for methods of treating disease using dichlorphenamide in conjunction with an organic anion transporter-1 (OAT1) substrate. The application details methods for administering the compounds and monitoring patient response and toxicity.

Intranasal Pharmaceutical Composition for Migraine Treatment

The USPTO has published a patent application (US20260083693A1) for an intranasal pharmaceutical composition containing ibuprofen and ketoprofen for treating migraine and headaches. The application details a method for manufacturing preparations with a combination of these active ingredients at reduced dosages compared to oral administration.

Composition of L-leucine and fish oil for muscle health

The USPTO has published a patent application (US20260083694A1) for a composition comprising L-leucine and fish oil, intended for muscle health and the prevention of muscle mass and strength loss. The application was filed by ABIOGEN PHARMA S.P.A.

Patent Application: Composition for Mitigating Veisalgia and Nausea

The USPTO has published a patent application (US20260083695A1) for a composition designed to reduce veisalgia (hangover) symptoms and nausea. The application details an orally deliverable formulation containing dihydromyricetin, acetylcysteine, and specific antiemetics, with a filing date of September 10, 2025.

Gamma-hydroxybutyrate Formulations with Improved Pharmacokinetics

The USPTO has published a new patent application, US20260083696A1, detailing modified release formulations of gamma-hydroxybutyrate with improved dissolution and pharmacokinetic properties. The application was filed on October 1, 2025, by inventors Jordan Dubow, Claire Megret, Hervé Guillard, and Jean-François Dubuisson.

Patent Application: Composition for Controlling Aquatic Organism Infections

The USPTO has published a new patent application (US20260083697A1) from B. G. Negev Technologies and Applications Ltd. The application details a composition containing an esterified fatty acid for preventing or treating monogenean infections in aquatic organisms.

Tennessee Rural Health Transformation Program Funding Info Session

The Tennessee Department of Health is hosting an information session on March 31, 2026, to detail funding opportunities for the Tennessee Rural Health Transformation Program (RHTP). This follows Tennessee's award of over $206 million in federal funding for rural health initiatives.

Patent for ultrasound BBB opening using physiologic signals

The USPTO has granted patent US12582849B2 to Cordance Medical Inc. for a device, method, and system to determine blood-brain barrier (BBB) opening or increased permeability during ultrasound procedures using physiologic signals. The patent was filed on November 14, 2024, and issued on March 24, 2026.

Patent Grant: Minimally Invasive Histotripsy Systems and Methods

The USPTO has granted a patent (US12582848B2) to The Regents of the University of Michigan for minimally invasive histotripsy systems and methods. The patent covers devices insertable endoscopically or laparoscopically for targeted tissue therapy.

Patent Grant for In Vivo Radiation Dosimetry Tool

The USPTO has granted a patent (US12582846B2) to The Regents of the University of California for an in vivo radiation dosimetry tool. This tool utilizes X-ray-induced acoustic computed tomography (XACT) to measure absolute radiation dose delivered during radiotherapy, aiming to improve precision and patient outcomes in cancer treatment.

Tendon repair implant and surgical instruments disclosed

The USPTO has granted a patent (US12582514B2) for a tendon repair implant and related surgical instruments. The patent, assigned to Ketonis Innovations LLC, details an implant with spikes for optimal tendon retention and associated surgical tools for precise placement.

Patent US12582513B2: Tool kit for tendon fixation implant

The USPTO has granted patent US12582513B2 for a tool kit designed for the minimally invasive implantation of tendon fixation implants in arthroscopic human medicine. The patent, assigned to INOVEDIS GmbH, details specific inserters and components for medical procedures.

USPTO Patent Grant for Omni-Abutment Core and Methods

The USPTO has granted patent US12582508B2 for an omni-abutment core and methods of use, assigned to ESTHETIC IMPLANT SOLUTIONS, LLC. This patent introduces novel features for dental abutments aimed at simplifying the restorative process and fabrication of dental prostheses.

Patent Grant for Surgical Field Data Visualization

The USPTO has granted patent US12582499B1 to Integro Theranostics, LLC for a system and method for visualizing fluorescing tissue in a surgical field. The patent covers technology that aids in identifying and displaying adjacent fluorescing tissue outside the immediate camera view.

Patent Grant for Surgical Video Stream Processing

The USPTO has granted patent US12582498B2 for a device that processes video streams from surgical operations. The patent, filed on June 11, 2021, describes a system for determining the progress of surgical steps based on image analysis.

Surgical robot endoscope mounting system patent granted

Surgical robot endoscope mounting system patent granted

Real-time Image Guided Portable Robotic Intervention System Patent Granted

The USPTO has granted a patent (US12582490B2) to Mendaera, Inc. for a real-time image guided portable robotic intervention system. The patent covers an image-guided robotic intervention system (IGRIS) designed to provide real-time views of patient anatomy and assist in planning and executing medical procedures.

Verb Surgical Inc. Granted Patent for Surgical Robotic System Control

The USPTO has granted a patent (US12582491B2) to Verb Surgical Inc. for a novel control system for surgical instruments within robotic systems. The patent focuses on reducing backlash and improving precision through a specific actuator control method.

Surgical instrument steering mechanism patent granted

The USPTO has granted a new patent (US12582493B2) for a surgical instrument steering mechanism developed by KARL STORZ SE & Co. KG. The patent covers a mechanism with two motorized drives designed to control the distal bending of surgical instruments. The filing date for this patent was July 25, 2022.

Georgia Tech Granted Patent for Neurosurgical Microrobots

The United States Patent and Trademark Office has granted a patent to Georgia Tech Research Corporation for a novel microrobot designed for neurosurgical applications. The patent, filed in July 2022, describes a magnetic microrobot that can be inserted into a patient and manipulated externally.

Microscopic Work Manipulator Patent Grant

The USPTO has granted patent US12582494B2 for a microscopic work manipulator developed by F.MED CO., LTD. The patent describes a parallel link mechanism with linear actuators and a hydraulic drive for rotating an end effector, intended for precise manipulation in microscopic procedures.

Patent Granted: Occlusal Force Meter Cover

The USPTO has granted a patent (US12582495B2) to MURATA MANUFACTURING CO., LTD. for a cover for an occlusal force meter. The patent was granted on March 24, 2026, and includes specific material and design requirements for the cover.

Headrest for patient immobilization system

The USPTO has granted patent US12582497B2 for a headrest designed for patient immobilization systems. The headrest features a supporting structure with an elastic panel that conforms to the patient's head and neck shape, intended for use in medical applications.

Ultrasonic Diagnostic Apparatus Patent Granted to FUJIFILM Corporation

The USPTO has granted patent US12587845B2 to FUJIFILM Corporation for an ultrasonic diagnostic apparatus. The patent covers technology related to wireless communication and group ID selection for establishing secure connections with information terminals.

Sony Olympus Patent for Photoelectric Module and Camera Head

The USPTO has granted a new patent (US12587727B2) to Sony Olympus Medical Solutions Inc. for a photoelectric composite module, camera head, and endoscopic device. The patent details specific technical components and their arrangement for use in medical imaging.

X-ray CT Apparatus and Method Patent Granted

The USPTO has granted a patent (US12586275B2) to Canon Medical Systems Corporation for an X-ray CT apparatus and method. The patent, effective March 24, 2026, relates to a photon counting detector and processing circuitry for determining scan transitions based on contrast agent presence.

Patent Grant: Image Processing, Diagnostic, Blood Pressure Monitor

The USPTO has granted a new patent (US12586191B2) to Canon Medical Systems Corporation for an image processing apparatus, medical image diagnostic apparatus, and blood pressure monitor. The patent, effective March 24, 2026, relates to specifying and displaying the acquisition position of blood flow indicators on medical images.

Blood Flow Extraction Image Forming Device Patent

The USPTO has granted patent US12586185B2 to FUJIFILM Corporation for a blood flow extraction image forming device. The patent details a method for creating images that distinguish blood flow from tissue components, utilizing correlation matrix calculations and singular value decomposition.

USPTO Patent Grant for Medical Imaging Systems

The USPTO has granted patent US12586196B2 to SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. for methods and systems for medical imaging. The patent covers techniques for generating images based on radiation events, incorporating both time-sensitive and non-time-sensitive response information.

Patent Grant for Memory Enhancement via EEG

The USPTO has granted patent US12586479B2 for an apparatus and method for memory enhancement based on electroencephalogram (EEG). The patent, assigned to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, aims to improve memory by identifying forgotten items during retrieval and providing personalized repetitive learning based on brain signals.

Patent US12586453B2: Radar, Camera, Mic System for Life Sign Monitoring

The USPTO has granted patent US12586453B2 to Innovative Health Monitoring LLC for a system and method to monitor a person's life signs using radar, camera, and microphone signals. The patent, effective March 24, 2026, aims to detect breathing or lack thereof and generate an alarm if no movement or breathing is detected for a selected period.

Patent US12585034B2: Electronic device with filter, scintillator, sensor

The USPTO has granted patent US12585034B2 to InnoCare Optoelectronics Corporation for an electronic device. The patent covers an electronic device comprising a scintillator layer, a sensor with distinct sensing units, and a filter with filter units of varying thicknesses. This grant is effective March 24, 2026.

X-ray detector patent granted to RAYENCE Co., Ltd.

The USPTO has granted patent US12585033B2 for an X-ray detector to RAYENCE Co., Ltd. The patent, effective March 24, 2026, covers a flexible X-ray detector design with integrated flexible circuit units and a main circuit unit.

Bragg Grated Fiber Optic Fluctuation Sensing and Monitoring System

The USPTO has granted patent US12584807B2 for a Bragg grated fiber optic fluctuation sensing and monitoring system to Bard Access Systems, Inc. The patent covers a system designed to detect damage to optical fibers used in medical devices by analyzing reflected light signals for strain-induced fluctuations.

Flexible Ultrasound Transducer Patent Grant US12585014B2

The USPTO has granted patent US12585014B2 for a flexible ultrasound transducer and an associated shape estimation method. The patent, assigned to KATHOLIEKE UNIVERSITEIT LEUVEN, details a system for determining the actual shape of flexible ultrasound devices.

X-ray aiming ring apparatus with connector and beam channel

The USPTO has granted patent US12585180B1 for an X-ray aiming ring apparatus. This patent, effective March 24, 2026, describes a device designed to improve the accuracy of X-ray machine positioning for diagnostic and surgical procedures.

Patent Grant: Image Pickup Module, Endoscope, and Manufacturing Method

The USPTO has granted a patent (US12585104B2) to OLYMPUS MEDICAL SYSTEMS CORP. for an image pickup module, endoscope, and manufacturing method. The patent details specific technical configurations for an image pickup module designed for use in endoscopes, focusing on resin application within its components.

AI Histological Fingerprinting Patent Granted to Siemens Healthineers

The USPTO has granted patent US12584984B2 to Siemens Healthineers AG for an AI-powered histological fingerprinting system. This patent covers methods for using AI to analyze magnetic resonance imaging data to map tissue microstructure, enhancing diagnostic capabilities.

Patent Grant for Scanning Object in Apparatus

The USPTO has granted patent US12584868B2 to Rolls-Royce PLC for a method of scanning an object within a scanning apparatus. The patent describes a specific method for placing an object into a jacket filled with material and scanning it using rotatable imaging elements.

Anti-vibration damping system for carbon fiber C-arm patent granted

The USPTO has granted a patent (US12584536B2) to GE Precision Healthcare LLC for an anti-vibration damping system for carbon fiber C-arms used in mobile X-ray imaging systems. The patent, effective March 24, 2026, aims to reduce vibrations during rotational movements of the C-arm.

Patent for Multi-User Device Activity Tracking

The USPTO has granted Motorola Mobility LLC a patent (US12582871B2) for techniques enabling multi-user activity tracking on a single device. This patent covers methods for detecting user device possession changes and tracking individual physical activity logs.

Patent: AI optimizes vehicle settings based on occupant state

The USPTO has granted a patent to Toyota Motor North America, Inc. for an AI system that optimizes vehicle settings based on occupant state and time of day. This patent covers the use of AI to adjust vehicle systems to enhance occupant comfort and condition.

Cannabis Products and Methods Patent Application

The USPTO has published a patent application (US20260083661A1) for cannabis-based products and methods, including lotions, soaps, perfumes, and teas. The application was filed on October 7, 2025, and lists Lawrence Lanier Long as the inventor.

Sunscreen Compositions and Methods of Use

The USPTO has published a patent application from Mary Kay Inc. detailing new sunscreen compositions designed to protect skin from UV radiation. The application describes specific formulations involving film formers and organic UV filters, along with methods of making and using these compositions.

KAO CORPORATION patent for hair treatment agent

The USPTO has published a patent application by KAO CORPORATION for a hair treatment agent. The application, filed on May 31, 2023, details a specific formulation involving film-forming polymers and organopolysiloxanes.

Oxazolidinone Liposome Compositions with Improved Storage Stability

The USPTO has published a new patent application from Akagera Medicines, Inc. detailing oxazolidinone liposome compositions designed for improved storage stability. The application, filed on December 2, 2025, describes methods for manufacturing and using these compositions.

High-Bioactivity Goat Colostrum Powder Preparation Method

The USPTO has published a patent application detailing a method for preparing a high-bioactivity goat colostrum composite freeze-dried powder. The invention focuses on enhancing the stability and survival rate of probiotics within the powder through encapsulation techniques.

Patent for Spray-Dried Amorphous Solid Dispersions Using Polyvinyl Alcohol

The USPTO has published a new patent application (US20260083676A1) detailing a method for preparing spray-dried amorphous solid dispersions of active pharmaceutical ingredients using polyvinyl alcohol. The application was filed on September 14, 2023, by inventors Lena Mueller, Laura Halstenberg, Thomas Kipping, and Nicole Di Gallo.

Patent Application: Solid Medicinal Forms with Stabilised Active Ingredient

The USPTO has published a new patent application (US20260083677A1) from Astellas Pharma Inc. The application describes solid medicinal forms containing active ingredients stabilized with specific drying agents, aiming for reduced moisture content. This is a new patent filing, not a regulatory rule or guidance.

Oral GLP-1 Compound Dosing Patent Application

The USPTO has published a patent application (US20260083678A1) related to oral dosing of GLP-1 compounds. The application was filed on December 3, 2025, by inventors Flemming S. Nielsen and Per Sauerberg, and relates to improved uses of GLP-1 peptides in oral therapy.

Adagrasib Solid Pharmaceutical Compositions for Treating Cancer

The USPTO has published a new patent application (US20260083679A1) detailing solid pharmaceutical compositions containing adagrasib for treating cancer. The application, filed on December 3, 2025, includes methods for manufacturing these compositions and treating cancer.

Mesoporous Nano-Magnesium Oxide for Drug Loading

The USPTO has published a patent application for a mesoporous nano-magnesium oxide material designed for drug loading. The application details the material's properties, including particle size and pore structure, and outlines a preparation method involving magnesium oxalate and CTAB.

Patent Application: Spray Dried Lipid Nanoparticle Formulations

The USPTO has published a patent application (US20260083681A1) detailing formulations for spray-dried lipid nanoparticle matrix particles. The application, filed on September 16, 2025, describes a composition including lipid nanoparticles, a buffer system, and a barrier matrix stabilizer. This publication is part of the patent application process and does not represent a final grant or regulatory requirement.

Kit for Drug-Containing Nanoparticles and Composition for Drug Delivery

The USPTO has published a new patent application (US20260083682A1) by SAMYANG HOLDINGS CORPORATION for a kit and composition for constructing drug-containing nanoparticles for enhanced drug delivery. The application details a method utilizing cationic compounds and anionic polymers to improve cellular drug delivery efficiency.

Protein Nanospheres for Treating Chemotherapy Dysfunction

The USPTO has published a patent application (US20260083683A1) for protein nanospheres designed to treat dysfunction caused by chemotherapy and immunosuppressive therapy. The application details the manufacture and use of fibrinogen-coated albumin spheres (FAS) and High-Fibrinogen Spheres (HFS) for mitigating toxic effects of cancer treatments.

CD3 Binding Antibodies Patent Application Inventors Listed

The USPTO has published a new patent application, US20260085115A1, related to CD3 binding antibodies. The application, filed on June 2, 2025, lists inventors Nathan Trinklein, Wim van Schooten, Shelley Force Aldred, Katherine Harris, and Duy Pham.

Anti-GPRC5D Antibody for Cancer Treatment

The USPTO has published a patent application (US20260085114A1) filed by Kyinno Biotechnology Co., Ltd. The application describes an anti-G protein-coupled receptor family class C group 5 member D (GPRC5D) antibody or fragment thereof for the treatment of tumors or cancers. It also details a bispecific antibody targeting GPRC5D and CD3.

Process for Isolating Osteopontin and Glycomacropeptide from Whey

The USPTO has published a new patent application (US20260085099A1) detailing a process for isolating osteopontin (OPN) and glycomacropeptide (GMP) from whey. The application, filed on September 15, 2023, describes a chromatography-based method for purification.

Patent Application: Method for Acute Respiratory Distress Syndrome Treatment

The USPTO has published a new patent application (US20260085098A1) from Revolo Biotherapeutics Limited for a method to treat acute respiratory distress syndrome. The application details a treatment method involving the administration of a specific peptide molecule during or in response to a relapse to induce remission.

DARPIN Compositions for Treating Shiga Toxin Diseases

The USPTO has published a patent application (US20260085097A1) detailing DARPIN-containing compositions for treating Shiga toxin diseases. The application highlights the thermostability and high microbial expression yield of DARPin as advantages over antibody therapeutics.

Patent Application: Detecting Pancreatic Cancer

The USPTO has published a patent application (US20260085360A1) detailing methods for detecting pancreatic cancer. The application describes a method involving measuring CA19-9 levels alongside other markers like OPN, MIA, and CEACAM-1 in a subject's sample.

Patent Application: Cancer Treatment Compositions and Methods

The USPTO has published a new patent application (US20260085120A1) for compositions and methods related to cancer treatment. The application describes binding agents, carrier proteins, and therapeutic agents, particularly for cancers expressing PD-LI or PD-L2, and lyophilized compositions.

Patent Application for Treating Cancer with Anti-CTLA4 Antibodies

The USPTO has published a new patent application (US20260085119A1) from ADAGENE PTE. LTD. for methods of treating cancers using anti-CTLA4 antibodies. The application details compositions and treatment methods, including combination therapies for cancers resistant to PD-1 or PD-L1 inhibitors.

Anti-CTLA-4 Antibody Conjugate Activated by Tumor Microenvironment

The USPTO has published a patent application (US20260085118A1) for a novel conjugate of an anti-CTLA-4 antibody activated by the tumor microenvironment. The application details a dual-activated conjugate designed to improve targeting efficacy, overcome drug resistance, and reduce toxicity.

Antibodies with chimeric constant domains reduce effector functions

The USPTO has published a patent application (US20260085117A1) detailing antibodies with chimeric constant domains designed to reduce effector functions. The application, filed on November 24, 2025, describes recombinant polypeptides and methods for their production.

Patent Application: Antibody Heavy Chain Regions Reduce Fc Gamma Receptor Binding

The USPTO has published a patent application (US20260085116A1) detailing antibody heavy chain constant regions modified to reduce binding to Fc gamma receptors. This modification, achieved through specific residue replacements or deletions in the hinge region, aims to decrease effector functions in antibodies and Fc fusion proteins.

Cleansing composition with carnosine, magnesium, caffeine

The USPTO has published a new patent application (US20260083658A1) for a personal cleansing composition. The composition includes carnosine, magnesium salt, caffeine, and transdermal absorption enhancers, designed for use in products like shower gels and soaps.

Skincare Therapeutic Balm Preparation Method Patent Application

The USPTO has published a patent application (US20260083662A1) for a skincare and therapeutic balm preparation method. The application, filed by Fine Washed LLC, details a method combining Ethiopian black seed oil with Illinois sourced beef tallow.

Botanical Compositions and Methods of Production and Use

The USPTO has published a new patent application, US20260083663A1, detailing botanical compositions with plant extracts and their preparation methods. The application was filed on September 11, 2023, and is scheduled for publication on March 26, 2026. This represents a new disclosure of potential intellectual property in the pharmaceutical sector.

Patent Application: Intrathecal T regulatory cells for Multiple Sclerosis Treatment

The USPTO has published a patent application (US20260083664A1) for a medicinal product involving intrathecal administration of T regulatory cells for treating multiple sclerosis. The application was filed on December 3, 2025, by inventors Piotr Trzonkowski and Kamil Chwojnicki.

USPTO Patent for Implantable Biodegradable Drug Delivery Devices

The USPTO has published a patent application (US20260083665A1) for implantable and biodegradable drug delivery devices. The invention aims to deliver active pharmaceutical ingredients directly to target tissue sites using layered biodegradable polymers.

Sulforaphane Supplement in Gummy Form Patent Application

The USPTO has published a patent application (US20260083667A1) for a sulforaphane supplement in gummy form. The application, filed by Sensory Scout LLC, describes a composition including sulforaphane, glucoraphanin, and myrosinase immobilized within a gummy matrix. This represents a new patent filing for a novel supplement formulation.

USPTO Patent Application for Disease Treatment Method

The USPTO has published patent application US20260083666A1 for a method of treating diseases and ameliorating pain by administering a composition to the ear canal. The application was filed on April 10, 2025, and published on March 26, 2026.

USPTO Patent for Orally Administered Corticosteroid Compositions

The USPTO has published a new patent application, US20260083668A1, for orally administered corticosteroid compositions. The patent, filed on November 28, 2025, by inventors Stephen Perrett, Fredric Jay Cohen, and Gopi M. Venkatesh, details pharmaceutical compositions and methods for treating gastrointestinal inflammation.

Aqueous Gel Composition for Administering Active Agents

The USPTO has published a new patent application, US20260083669A1, filed by Acousia Therapeutics GmbH. The application describes an aqueous gel composition useful for administering pharmaceutically active agents, particularly for transtympanic administration.

Adenovirus Formulation with Citrate Buffer and Salt

The USPTO has published a new patent application (US20260083670A1) for an adenovirus formulation. The formulation includes a recombinant adenovirus, citrate buffer, cyclodextrin compound, and salt, with a pH between 5.5 and 6.5, and is free of non-ionic detergent. The invention also covers a method for preserving adenoviruses using this formulation.

Patent Application for Stabilized Galectin-9 Protein Pharmaceutical Formulation

The USPTO has published a patent application (US20260083671A1) for a stabilized pharmaceutical formulation containing a recombinant stabilized galectin-9 protein. The application details a formulation designed for improved stability through the combination of a buffer and a stabilizer.

Oil-in-water emulsions for topical administration with hyaluronan

The USPTO has published a patent application (US20260083673A1) for oil-in-water emulsions containing hyaluronan for topical administration. The application details formulations for treating various dermatological conditions, including inflammatory dermatoses, acne, alopecia, and fibrosing pathologies.

Patent Application for Contrast Agents in Diagnostic Imaging

The USPTO has published a patent application (US20260083864A1) for a new class of compounds intended for use as contrast agents in diagnostic imaging, including computed tomography (CT) and magnetic resonance imaging (MRI). The application details specific compound formulas, metal chelates, and preparation methods.

USPTO Patent Application for PSMA Ligands

The USPTO has published a new patent application (US20260083865A1) filed by 3B Pharmaceuticals GMBH for prostate specific membrane antigen (PSMA) ligands. The application details a compound of Formula (I) and its use in treating cancer.

Patent Application: Tumor Targeting Methods and Reagents

The USPTO has published a patent application (US20260083867A1) detailing methods and reagents for tumor targeting in cancer treatment. The application, filed on November 21, 2025, describes a combination therapeutic approach using agents with different biodistributions to enhance efficacy and reduce toxicity.

Patent Application for Genome Editing Compositions and Methods

The USPTO has published a new patent application (US20260083860A1) for genome editing compositions and methods. The application, filed on August 19, 2025, by inventors Oscar ALVAREZ, Ming-Yue LEE, and Blair B. MADISON, details methods and compositions for functional genetic modifications.

CRISPR Methods Targeting CD70 Expression for Engineered Cells

The USPTO has published a patent application (US20260083861A1) filed by Editas Medicine, Inc. The application describes CRISPR-related systems and methods for targeting the CD70 gene expression in engineered cells, particularly T cells, for potential therapeutic applications.

Patent Application: Treating Brain Diseases with rAAV Particles

The USPTO has published a new patent application (US20260083862A1) from the University of Iowa Research Foundation detailing methods for treating brain diseases using rAAV particles administered via the cisterna magna. The application was filed on May 19, 2025.

Patent Application: Compositions with Sophorolipids and Lactic Acid

The USPTO has published a new patent application (US20260083655A1) filed by Evonik Operations GmbH. The application describes compositions containing sophorolipids and lactic acid for cleaning or skin moisturizing. This is a routine filing for a new patent application.

Patent Application for Hyaluronic Acid Production Stimulation

The USPTO has published a new patent application (US20260083656A1) filed by Alastin Skincare, Inc. The application details compositions and methods for stimulating intrinsic hyaluronic acid production to improve skin moisture and elasticity. This is a routine publication of a patent application.

Patent Application for Whitening Cosmetic Composition with Artemisinic Acid

The USPTO has published a patent application (US20260083657A1) for a whitening cosmetic composition containing artemisinic acid, nicotinamide, and/or glutathione. The application, filed by Yunnan Botanee Bio-Technology Group Co., Ltd., describes a formulation designed to inhibit melanin production and reduce skin irritation.

FIBRIBION Trademark Publication

The USPTO has published the FIBRIBION trademark application for opposition. The application covers nutritional supplements, probiotic compositions, and dietary supplements. The publication date is March 25, 2026.

HEALTHYBLOOD Trademark Published for Opposition

The USPTO has published the HEALTHYBLOOD trademark application for opposition. The application covers various types of nutritional and dietary supplements. The publication date was March 25, 2026, with a filing date of March 24, 2026.

VERIXA trademark application published for opposition

The USPTO has published the trademark application for 'VERIXA' for opposition. The application covers insect repellents, insecticides, and rodenticides. The filing date was March 24, 2026, and the publication date is March 25, 2026.

BIOTHRIVE Trademark Application - Intent to Use

The USPTO has received an intent-to-use trademark application for the mark 'BIOTHRIVE' filed on March 24, 2026. The application covers health food supplements, dietary supplements, herbal supplements, and vitamin and mineral supplements.

ELTHYSIA Trademark Application - Intent to Use

The USPTO has recorded an intent-to-use trademark application for the mark 'ELTHYSIA'. The application covers a wide range of products including vitamins, dietary supplements, and pet supplements. The filing date for this application was March 24, 2026.

ASTANEURO Trademark Application Published for Opposition

The USPTO has published the trademark application for ASTANEURO, filed on March 24, 2026, for opposition. This notice indicates the application is now open for challenges from other parties before it can be registered.

NALIRFAL Trademark Application Published for Opposition

The USPTO has published the trademark application for NALIRFAL, which includes a variety of dietary and nutritional supplements. The application was published for opposition on March 25, 2026, with a filing date of March 24, 2026. This publication initiates a period during which other parties may oppose the trademark registration.

NOURISHA intent to use trademark application details

The USPTO has recorded an intent-to-use trademark application (TM99692572) for the mark 'NOURISHA'. The application covers a range of pharmaceutical and food-related products, including milk-based nutritional supplements and dietetic preparations. The filing date for this application was March 10, 2026.

KYNTO Trademark Published for Opposition

The USPTO has published the KYNTO trademark application for opposition, related to dietary supplements. The application was filed on March 24, 2026, and the publication date for opposition is March 25, 2026. This marks a step in the trademark registration process.

JOINT AND JOINT Trademark Published for Opposition

The USPTO has published the trademark application for 'JOINT AND JOINT' for health food supplements, initiating a 30-day opposition period. The application was filed on March 24, 2026, and published for opposition on March 25, 2026.

Vitaminloft Intent to Use Trademark Application

The USPTO has published details for an intent-to-use trademark application for the mark 'VITAMINLOFT'. The application covers a wide range of pharmaceutical and health-related products, including supplements, vitamins, topical preparations, and disinfectants.

VALISSE intent to use trademark application filed

The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for the mark 'VALISSE'. The application, filed on March 24, 2026, covers health food supplements, dietary supplements, herbal supplements, and vitamin and mineral supplements.

KARENZA Trademark Intent to Use Application

The USPTO has received an intent-to-use trademark application for the mark 'KARENZA' for use with dietary supplements. The application was filed on March 24, 2026, and is designated for Class 005.

PRÜF Intent to Use Trademark Application Filed

The USPTO has received an intent-to-use trademark application for the mark 'PRÜF' filed on March 25, 2026. The application, filed on September 24, 2025, pertains to dietary and nutritional supplements.

HIVANO Intent to Use Trademark Application

The USPTO has received an intent-to-use trademark application (TM99722503) for the mark 'HIVANO'. The application covers a wide range of goods including athletic apparel, footwear, and various supplements (probiotic, homeopathic, mineral, herbal, vitamin, calcium, food, dietary, nutritional, and natural herbal). It also includes services related to nutrition counseling and information provision.

POWERSTOVE Trademark Application Published for Opposition

The USPTO has published the trademark application for 'POWERSTOVE' for opposition. The application covers a range of products including personal sexual lubricants, dietary supplements, pet supplements, vitamins, and other health-related items. The publication date for opposition is March 25, 2026.

TEMIMAR trademark application published for opposition

The USPTO has published the trademark application for 'TEMIMAR' for opposition. The application covers natural herbal supplements, vitamin supplements, and other health-related food products. The publication date is March 25, 2026.

7 LIFE Trademark Application Published for Opposition

The USPTO has published the trademark application for '7 LIFE' for opposition. The application, filed on March 24, 2026, is for dietary supplements. The publication date is March 25, 2026, initiating a period for potential opposition.

CHIGGER OFF Intent to Use Trademark Application

The USPTO has received an Intent to Use trademark application for 'CHIGGER OFF' for topical dermatological preparations. The application was filed on March 24, 2026, with an effective date of March 25, 2026. This filing pertains to a new product intended to treat insect bites and stings.

JUVONA intent to use trademark application filed

The USPTO has received an intent-to-use trademark application for the mark 'JUVONA' filed on March 25, 2026. The application covers goods including dietary supplements, nutritional supplements, and nutraceuticals for human consumption.

Shielded Bag for Radioactive Medicaments Delivery System

The USPTO has published a new patent application (US20260083981A1) for a shielded bag designed for delivering radioactive medicaments. The application, filed by Christopher James Franzese and Martin Michael Coyne, III, details a multi-layered container for storing and transporting radiopharmaceuticals.

Pumping Device Patent Application Published

The USPTO published a patent application for a new pumping device designed for feeding liquid to patients. The application, filed on September 25, 2024, describes a disposable pumping cartridge and a reusable drive unit, aiming for economical assembly and use.

Implantable Reservoir for Iontophoresis Drug Delivery System

The USPTO has published a new patent application (US20260083966A1) for an implantable reservoir designed for iontophoresis drug delivery systems. The application details a reservoir for local drug delivery through internal or external body tissue, potentially including chemotherapeutic agents or ribonucleic acid molecules.

Patent Application for Patient Health Monitoring Device

The USPTO has published a new patent application (US20260083959A1) for a patient health monitoring device and method. The application details a device that processes pressure signals to monitor a patient's health state. This is a routine publication of a new patent application.

Medical Fluid Pump Patent Application

The USPTO has published a new patent application (US20260083958A1) for a fluid pump device, particularly for medical applications. The application was filed on December 2, 2025, and published on March 26, 2026.

Medical Device Patent: Circulatory Support System with Diaphragm Pump

The USPTO has published a new patent application (US20260083957A1) for a circulatory support system with a diaphragm pump, assigned to Boston Scientific Scimed, Inc. The application details a percutaneous circulatory support device system designed to pump blood.

Mechanical Circulatory Support System Patent Application

The USPTO has published a new patent application (US20260083956A1) for a mechanical circulatory support system with a repositioning sheath, assigned to Boston Scientific Scimed, Inc. The application details a medical device system designed to pump blood from a patient's heart ventricle to the vasculature.

USPTO Patent Application for Blood Pump Outflow Window Markings

The USPTO has published a new patent application (US20260083955A1) filed by Boston Scientific Scimed, Inc. The application describes percutaneous blood pump outflow window markings for a circulatory support device. This is a routine publication of a patent application.

Base Editing of Plant Cell Organelle DNA

The USPTO has published a patent application (US20260085323A1) detailing a method for base editing plant cell organelle DNA. The application, filed by the Institute for Basic Science, describes a composition and method for editing adenine to guanine and cytosine to thymine in plant cell organelle DNA.

Metabolic Selection via Serine Biosynthesis Pathway Patent Application

The USPTO has published a new patent application, US20260085327A1, related to metabolic selection via the serine biosynthesis pathway. The application details an isolated mammalian cell with reduced expression of Phosphoserine Phosphatase (PSPH) and its use in recombinant protein production.

Patent Application for Endoglin Antibodies Detecting Cancer Splice Variants

The USPTO has published a patent application (US20260086096A1) for endoglin antibodies designed to detect cancer splice variants. The application, filed by Nam Yong Lee, details methods and compositions for improved cancer diagnosis.

Karyocreate Patent Application US20260085330A1 Details CRISPR Technology

The USPTO has published patent application US20260085330A1 from Karyocreate detailing CRISPR technology for inducing aneuploidy. The application, filed on September 8, 2023, describes fusion proteins and guide RNAs that interfere with chromosome segregation.

Cell Culture Method Suppressing Foam Aggregates

The USPTO has published a new patent application (US20260085282A1) from FUJIFILM Corporation detailing a cell culture method. The method aims to suppress foam aggregate formation by adjusting poloxamer concentration or foam liquid viscosity during cell culture at high densities.

Methods for Separating Chelator from Mixture Using Chromatography

The USPTO has published a new patent application, US20260085108A1, detailing methods for separating a chelator from a mixture using chromatography. This application, filed on September 8, 2023, by inventors Jason Huang and Qiang Li, describes techniques useful in adjusting the concentration of chelators in protein compositions.

Ginkgo Bioworks Patent for Protein Production and Secretion Systems

The USPTO has published a new patent application (US20260085107A1) filed by Ginkgo Bioworks, Inc. The patent describes expression systems for enhanced production and secretion of proteins, including specific examples like bovine lactoferrin. This application is part of the ongoing patent process for novel biotechnological methods.

Chimeric Antigen Receptor System for Signalling

The USPTO has published a new patent application, US20260085106A1, detailing a chimeric antigen receptor (CAR) system. This system is designed to control signalling based on the presence or absence of a specific agent, potentially impacting the development of targeted therapies.

MAGEA4 Specific T Cell Receptors Patent Application

The USPTO has published a patent application (US20260085105A1) filed by Amgen Inc. for recombinant T-cell receptors designed to selectively recognize MAGE-A4-derived peptides. The application details screening for cross-reactivity and alloreactivity.

Patent Application: Multispecific Binding Constructs Against Checkpoint Molecules

The USPTO has published a new patent application (US20260085121A1) from Compass Therapeutics, LLC, detailing multispecific binding constructs against checkpoint molecules. The application focuses on compositions and methods for inhibiting tumor evasion by reducing immune checkpoint suppression, specifically blocking interactions between PD-1 and its ligand.

Patent Application: Antibodies Binding Human 4Ig-B7H3

The USPTO has published a new patent application (US20260085122A1) filed by BeOne Medicines I GmbH. The application relates to antibodies or antigen-binding fragments thereof that bind to human 4Ig-B7H3.

Patent Application: Anti-FGFR2 Antibodies with Chemotherapy for Cancer Treatment

The USPTO has published patent application US20260085123A1, filed by Five Prime Therapeutics, Inc. The application details the use of anti-FGFR2 antibodies in combination with mFOLFOX6 chemotherapy for treating certain cancers.

Patent Application for Tenosynovial Giant Cell Tumor Treatment

The USPTO has published a patent application (US20260085124A1) detailing compositions and methods for treating tenosynovial giant cell tumor using intra-articular delivery of anti-CSF1R antibodies. The application, filed by Kirk William Johnson, focuses on sustained drug exposure within joints.

Patent Application for Apelin Receptor Binding Polypeptides and Methods

The USPTO has published a new patent application (US20260085125A1) for apelin receptor binding polypeptides and methods of treatment. The application was filed on November 25, 2025, and details antibodies and polypeptides that specifically bind to the apelin receptor (APJ).

Patent Application for Agonistic TNF Receptor Binding Agents

The USPTO has published a new patent application, US20260085126A1, for agonistic TNF receptor binding agents. The application, filed on August 27, 2025, by inventors including Ugur Sahin, details binding agents for TNF superfamily receptors and their potential medical uses.

Bispecific Antibody Targets TIM-3 and CD39 for Cancer

The USPTO has published a patent application (US20260085127A1) for a bispecific antibody designed to target both TIM-3 and CD39 antigens. This antibody aims to enhance immune activity against cancer cells and is intended for cancer treatment.

Anti-CD157 Antibodies, Fragments, Compositions, and Methods

The USPTO has published a patent application (US20260085128A1) detailing anti-CD157 antibodies, antigen-binding fragments, compositions, and methods for their use. The application was filed on July 18, 2023, and describes potential diagnostic reagents and kits.

CD163 Binding Protein Patent Application

The USPTO has published a patent application (US20260085129A1) filed by ECO ANIMAL HEALTH LTD. on October 11, 2023. The application relates to an antibody that binds to porcine CD163, specifically its membrane-bound form.

Patent Application for Detecting Immune Cells Using Fusion Proteins

The USPTO has published a new patent application (US20260085104A1) detailing fusion proteins for detecting and isolating immune cells. The application, filed by Patrick Schlegel, describes specific fusion proteins involving a dysfunctional purinergic P2X7 receptor epitope and an antibody Fc region.

Long-acting insulin compound for treating diabetes

The USPTO has published a patent application (US20260085103A1) for a long-acting insulin compound designed for treating diabetes. The application details the compound's use in pharmaceutical compositions for conditions including type-I, type-II, and gestational diabetes.

Patent Application for Synthetic Promoters and Circuits in Cancer Cells

The USPTO has published a patent application (US20260085102A1) for nucleic acid molecules designed to specifically express sequences of interest in cancer cells. The application details synthetic promoters and circuits for use in cancer treatment.

Novel Platelet Derived Growth Factor Peptide Mimetic for Cardiac Repair

The USPTO has published a patent application (US20260085101A1) for a novel platelet-derived growth factor peptide mimetic designed for cardiac repair, particularly post-infarction. The application details specific compounds, their preparation, and methods of use.

US Patent Application for Antigen Production Methods

The USPTO has published a new patent application (US20260085100A1) from The Wistar Institute of Anatomy and Biology detailing methods for manufacturing individualized vaccines. The application focuses on nucleic acid molecules encoding neoantigens specific to tumor antigens for use in subject immunization.

Stabilized trimeric class I fusion proteins patent application

The USPTO has published a patent application (US20260085096A1) for stabilized trimeric class I fusion proteins. The application details specific mutations in the HR2 domain to enhance protein stability. This is a routine publication of a new patent application.

Patent Application for AAV Capsid Variants and Uses

The USPTO has published a new patent application (US20260085095A1) detailing adeno-associated virus (AAV) capsid variants and their uses. The application was filed on June 1, 2023, and is scheduled for publication on March 26, 2026. This represents a new disclosure in the field of gene therapy vectors.

Stapled Peptide and Use Thereof Patent Application

The USPTO has published a patent application (US20260085094A1) for a stapled peptide and its use, filed by inventors Zhixiang PAN, Haiying HE, Zhigan JIANG, and Shuhui CHEN. The application details a series of stapled peptides, specifically relating to polypeptides with sequences shown in formulas (I-1)-(I-5) and (II-6), and their pharmaceutically acceptable salts.

Melanocortin Receptor Ligands Patent Application

The USPTO has published a new patent application (US20260085092A1) for compounds acting as ligands for melanocortin receptors. The application details specific compounds and their potential use in treating mammals, filed by inventors Zeng Xin Dong and Jacques-Pierre Moreau.

Patent Application: Peptide Binds Trop2 for Cancer Treatment

The USPTO has published a patent application (US20260085091A1) from Kyungpook National University Industry-Academic Cooperation Foundation for a peptide that selectively binds to Trop 2. The peptide is intended for targeted therapeutic agents and anticancer drugs for resistant cancers such as breast, pancreatic, and cholangiocarcinoma.

Method for Reducing Host Cell Proteins in Affinity Chromatography

The USPTO has published a patent application from Genentech, Inc. detailing a method for purifying antibodies by reducing host cell proteins using a low conductivity aqueous solution in affinity chromatography. This application, filed on December 2, 2025, describes a specific purification technique for biopharmaceutical products.

Patent Application for Chromatographic Fractionation Method

The USPTO has published a new patent application (US20260085089A1) detailing a method and apparatus for continuous gradient elution chromatographic fractionation. The application, filed on September 12, 2023, describes a process for separating products of interest from impurities using chromatography matrices and elution solutions.

Method for preparing biologically active complexes using polypeptides and oleic acid

Method for preparing biologically active complexes using polypeptides and oleic acid

Takeda's Monoclonal Antibody Inhibitor of Factor XIIa Patent Application

The USPTO has published a patent application from Takeda Pharmaceutical Company Limited for a monoclonal antibody inhibitor of Factor XIIa. The application, filed on August 12, 2025, describes methods for treating diseases associated with Factor XII, including hereditary angioedema and ocular diseases.

Patent Application: Bispecific Antibodies and Uses Thereof

The USPTO has published a new patent application (US20260085131A1) for bispecific antibodies and their uses. The application, filed on August 20, 2025, describes antibodies that bind to two different antigens with varying affinities.

Patent Application for Free LIGHT Detection and Treatment

The USPTO has published a patent application (US20260085112A1) from Avalo Therapeutics, Inc. for methods of detecting and treating conditions associated with elevated free LIGHT using anti-LIGHT antibodies. The application covers methods for diagnosing conditions like acute lung injury, ARDS, and Crohn's Disease.

Patent Application for SLIT2 Related Compositions and Methods

The USPTO has published a new patent application (US20260085111A1) filed by EVEREST MEDICINES (SINGAPORE) PTE. LTD. The application relates to antibodies that bind to SLIT2 and related substitution mutants, including their manufacture and use.

Patent Application: Production Method for Product to Prevent Membrane Clogging

The USPTO has published a patent application from FUJIFILM Corporation detailing a production method for a product that aims to prevent membrane clogging during cell culture. The method involves specific mathematical expressions related to poloxamer concentration, product concentration, and hydrophobicity index to optimize the cell culture process.

Patent Application: Filtration Condition Evaluation and Cell Product Production

The USPTO has published a new patent application (US20260085109A1) from Asahi Kasei Life Science Corporation detailing a method for evaluating filtration conditions and producing cell products. The application was filed on November 14, 2023, and published with a projected application date of March 26, 2026.

All-in-one Agonistic Antibodies Patent Application

The USPTO has published a patent application (US20260085113A1) filed by Hoffmann-La Roche Inc. on October 2, 2025. The application describes antigen binding molecules comprising biparatopic target-binding domains and cytokine receptor-binding domains designed to selectively activate cytokine receptors.

Heterodimeric Human IgG1 Polypeptides with Isoelectric Point Modifications

The USPTO has published a new patent application, US20260085132A1, titled 'Heterodimeric Human IgG1 Polypeptides with Isoelectric Point Modifications'. The application details methods for purifying desired heterodimer immunoglobulin variants from contaminating homodimer variants by modifying isoelectric points.

Polyproline Nanocage Compound and Manufacturing Method

The USPTO has published a patent application for a polyproline nanocage compound and its manufacturing method. The application details a compound comprising two cyclic peptide scaffolds connected by molecules, with each scaffold containing polyproline helix rods and turn-angle molecules. This is a routine publication of a new patent application.

USPTO Patent Application for Fusion Polypeptides

The USPTO has published a new patent application (US20260085300A1) detailing systems and compositions for fusion polypeptides and their methods of use in regulating target genes. The application was filed on October 27, 2023, by inventors Thomas Blair Gainous, Xiao Yang, Giovanni Carosso, Lei S. Qi, and Daniel O. Hart, II.

ANSM Recalls Omnipaque and Visipaque Lots Due to Particle Contamination

ANSM has issued a precautionary recall, in coordination with GE Healthcare SAS, for specific lots of Omnipaque 350 mg I/mL and Visipaque 320 mg I/mL injectable solutions (100 mL vials). The recall was initiated after particles were detected adherent to the internal wall of certain vials. If these particles detach and are not detected prior to injection, they may pose a patient safety risk. Healthcare establishments, pharmaceutical distribution channels, and professionals who received affected lots are being notified directly.

ANSM Safety Alert: Atellica CH Urine Albumin Reagent

The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the Atellica CH Urine Albumin reagent from Siemens Healthcare Diagnostics Inc. The alert, registered under number R2602998, informs medical biology laboratories of a safety action implemented by the manufacturer.

ANSM Security Alert for Orbis Medication Prescription Aid Software

The ANSM has issued a security alert (R2608925) regarding the Orbis Medication prescription aid software (version 3.x) from DH Healthcare GMBH. Affected healthcare providers have been notified directly by the company.

Product Recall: Klassiker Crutches and Rubber Tips

The ANSM has been informed of a product recall for Klassiker crutches and rubber tips, initiated by Ossenberg GmbH. This safety action, registered under number R2603198, affects pharmacies, community care facilities, large and medium-sized stores, and home healthcare providers. Affected users have been notified directly by the manufacturer.

Resoundant Acoustic Transducer for MRI - Safety Action

The French National Agency for Medicines and Health Products Safety (ANSM) has registered a safety action concerning the Resoundant acoustic transducer for MRI, identified under number R2606244. Healthcare facilities and medical imaging centers using this device have been notified.

Patent Application: Treating Blood Clots with Nerve Stimulation

The USPTO has published a patent application from ElectroCore, Inc. detailing systems and methods for treating blood clots using nerve stimulation, particularly for post-COVID conditions. The application describes transcutaneous electrical impulses to a vagus nerve branch to reduce antibodies associated with blood clotting.

USPTO Patent: Convert Chest Radiology Data to Numerical Vectors

The USPTO has published a patent application detailing a method and device for converting chest radiology data into numerical vectors using deep learning algorithms. This technology aims to analyze, predict, or diagnose diseases based on extracted anatomical and disease-related features from the data.

Medical Application Live Chat and Voice Assistant Patent Filed

The USPTO has published a patent application (US20260088188A1) for a live chat and voice assistant platform designed for medical applications. The system aims to facilitate messaging between medical applications on doctor and patient devices.

Patent Application for Blood Flow and Shear Stress Calculation

The USPTO has published a patent application (US20260088181A1) for a method to calculate blood flow and shear stress in aortas with bicuspid aortic valves. The application, filed by the University of Seoul Industry Cooperation Foundation, details a process using characteristic values of the valve to compute these metrics.

NEC Corporation Patent for Information Processing Device

The USPTO has published a patent application from NEC Corporation for an information processing device. The device utilizes machine learning models to analyze human feature values and set types associated with these models, aiding in user decision-making.

Prediction Device, Method, and Non-Transitory Computer-Readable Recording Medium

The USPTO has published a patent application (US20260088183A1) by NEC Corporation for a prediction device and method. The invention aims to support decision-making regarding a target person's health by analyzing health data distributions across different age groups.

Lung function curve prediction method and apparatus

The USPTO has published a patent application detailing a method and apparatus for predicting lung function curves. The invention uses a Taylor series expansion to model the relationship between flow rates at different sampling points, enabling prediction of true lung function curve data from a finite set of points.

Computer-assisted method for patient examination positioning information

The USPTO has published a new patent application (US20260088186A1) from Siemens Healthineers AG for a computer-assisted method to generate patient examination positioning information. The application details a system that uses image data and an evaluation model to create positioning data for examination protocols.

Bifunctional degraders with electrophilic PROTACs

The USPTO has published a patent application (US20260083722A1) detailing bifunctional degraders comprising electrophilic PROTACs that engage DCAF1. The application was filed on May 19, 2023, and published with a projected application date of March 26, 2026.

Patent Application for Reducing Food Intake Using Plants

The USPTO has published a new patent application (US20260083800A1) detailing methods and compositions using Dichrostachys glomerata or Cissus quadrangularis to reduce food intake or appetite in mammals. The application was filed on September 26, 2024, by inventors Shil Kothari and Julius Enyoug Oben.

Patent Application for Reducing Visceral Fat Using Plants

The USPTO has published a new patent application (US20260083801A1) detailing methods and compositions for reducing visceral fat in mammals using plants like Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.

Patent Application: Methods for Reducing Blood Lipids Using Plants and Spices

The USPTO has published a new patent application (US20260083802A1) detailing methods and compositions for reducing blood lipids using plants and spices, specifically Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024.

Patent Application for Reducing Blood Glucose with Plants

The USPTO has published a new patent application (US20260083803A1) detailing methods and compositions for reducing fasting blood glucose in mammals using plants like Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.

Patent Application: Reducing DPP-4 Activity Using Plants

The USPTO has published a new patent application (US20260083804A1) detailing methods and compositions for reducing DPP-4 activity using plants like Dichrostachys glomerata or Cissus quadrangularis. The application, filed on September 26, 2024, aims to provide health benefits such as increased GLP-1 levels and reduced visceral fat.

Phytogenic Composition for Animal Skeletal Muscle Growth

The USPTO has published a patent application (US20260083805A1) detailing a phytogenic composition comprising Glycyrrhiza uralensis extract for promoting skeletal muscle growth in animals. This application outlines its use as a feed additive for agricultural applications.

Patent application for Dichrostachys glomerata health and wellness benefits

Patent application for Dichrostachys glomerata health and wellness benefits

Rosalind Franklin University Trademark Registration

The United States Patent and Trademark Office has registered the trademark 'Rosalind Franklin University' (TM86537927) on March 25, 2026. The registration covers a broad range of medical, health, and educational services, including dietary guidance, medical consultations, research services, and patient education.

Rosalind Franklin University trademark registered for medical services

The USPTO has registered trademark TM86537923 for Rosalind Franklin University of Medicine and Science, covering a range of medical and educational services. The trademark was filed on February 18, 2015, and registered on March 25, 2026.

Marshall Health Trademark Registration TM85695960

The USPTO has registered trademark TM85695960 for Marshall Health, covering various medical services including family medicine, pediatrics, surgery, and oncology. The registration was finalized on March 25, 2026, following an initial filing date of August 6, 2012.

Luxurious Wellniss Intent to Use Trademark Application

The USPTO has recorded an intent-to-use trademark application for 'Luxurious Wellniss' filed on September 16, 2019. The application abstract describes providing a website featuring information about health, wellness, and nutrition. The application is designated for Class 044, which typically covers medical services.

St. Baldrick's Foundation Care Trademark Application

The St. Baldrick's Foundation has filed an intent-to-use trademark application (TM97113127) for "St. Baldrick's Foundation Care." The application covers consulting services related to childhood cancer treatment, research, and clinical trials, as well as educational programs in the field.

SKIN PERFECT trademark registered for health spa services

The USPTO has registered the trademark SKIN PERFECT for health spa and cosmetic body care services. The registration was finalized on March 25, 2026, based on a filing date of May 15, 2015.

CANCERMAP Trademark Registration - Medical Consultancy

The United States Patent and Trademark Office has registered the trademark "CANCERMAP" (TM86285985) for medical consultancy services. The registration was finalized on March 25, 2026, following a filing date of May 20, 2014.

Happy Detox Trademark Published for Opposition

The USPTO has published the trademark application 'Happy Detox' for opposition. This publication indicates that the trademark application has passed initial examination and is now open for public objection before final registration. The trademark covers a wide range of food and beverage products, as well as cosmetics and related services.

Drybar Registered Trademark for Hair and Beauty Salon Services

The USPTO has registered the trademark TM85672274 for Drybar, covering hair and beauty salon services. The trademark was registered on March 25, 2026, following a filing date of July 9, 2012.

AI Prescription Prior Authorization Validation Patent Application

The USPTO has published a patent application (US20260088148A1) detailing an AI-based method for validating prescription prior authorization documentation. The application, filed on September 19, 2025, describes a system that uses machine learning to analyze documentation and determine authorization approval or rejection.

Flow Meter and Related Method Patent Application

The USPTO has published a patent application (US20260088149A1) for a flow meter and related method filed by DEKA Products Limited Partnership. The application describes an image-based gravity-driven infusion system that uses camera monitoring to regulate flow, with an optional physics-based model for enhanced accuracy and safety.

Infusion Systems and Methods for Patient Activity Adjustments

The USPTO has published a new patent application (US20260088150A1) detailing infusion systems and methods for adjusting patient treatment based on historical activity and nutritional data. The application focuses on personalized insulin dosage determination for patients.

AI Dose Computation for Radiation Therapy Using Medical Images

The USPTO has published a patent application detailing an AI system for calculating radiation therapy doses using medical images. The application, filed by Martin Kraus and colleagues, describes a method that uses machine learning to determine multi-field doses based on patient images and fluence maps.

NEC Corporation Patent for AI Assessment Support System

The USPTO has published a patent application by NEC Corporation for an AI assessment support system. The system uses machine learning to predict patient assessment vectors and identify similar patients based on nursing record data.

Ophthalmic System and Behavior Modification Support Method Patent Application

The USPTO has published a patent application (US20260088172A1) for an ophthalmic system and behavior modification support method assigned to Topcon Corporation. The application describes a system involving patient and medical institution terminals to manage information sharing and communication, with a function to prompt behavior modification for disease treatment based on personality test results.

Patent Application: Explainable AI for Medical Decisions

The USPTO has published a patent application (US20260088173A1) detailing methods and systems for evaluating the faithfulness of explainable AI in medical decision-making. The application focuses on fine-tuning classifiers and ensuring explainer model fidelity for downstream tasks.

Patent Application: Predicting ICU Patient Length of Stay

The USPTO has published a new patent application (US20260088160A1) detailing methods and systems for predicting a patient's length of stay in an intensive care unit (ICU). The application describes improved predictive models that analyze patient data to generate LOS predictions.

Patent for Long Term Care Facility Ecosystem and Platform

The USPTO has published a patent application for an ecosystem and platform designed for long-term care facilities. The application, filed by BioLink Systems LLC, aims to improve medical data flow, staff compensation, and overall operations within nursing homes.

Health Future Projector Patent Application Filed

The USPTO has published a patent application (US20260088179A1) filed by Toyota Research Institute, Inc. The application describes a 'Health Future Projector' system that uses AI to predict future health information and generate visualizations for users based on their demographic, health, and behavioral data.

Patent Application for Medical Imaging Image Processing

The USPTO has published a new patent application (US20260087616A1) from Canon Medical Systems Corporation for a method of processing image data in medical imaging systems. The application details a technique using neural networks to improve image quality from input data, potentially enhancing diagnostic capabilities.

Patent Application: Model for Detecting Atrial Fibrillation and Sleep Apnea

The USPTO has published a patent application (US20260088174A1) for a method of establishing a model to detect atrial fibrillation and sleep apnea using machine learning. The application details a process involving training electrocardiograms, feature extraction, and symptom labeling.

Data-driven mental health programming patent application

The USPTO has published a new patent application, US20260088152A1, filed by Charlie Health, Inc. The application details methods and systems for data-driven mental health programming, including ingesting patient data into a knowledge graph, deriving patient archetypes, and assigning patients to therapists and treatment modalities based on this data.

Patent Application: Inferring Patient Condition Using Machine Learning

The USPTO has published a patent application (US20260088175A1) filed by Hill-Rom Services, Inc. The application details a machine learning system designed to infer a patient's condition using sensor data and response variable data. This technology aims to improve patient monitoring and diagnostics.

NEC Corporation Patent Application for Estimation Device

The USPTO has published a patent application from NEC Corporation for an estimation device. The application, filed on December 2, 2025, describes a system that extracts gait waveform features to estimate a user's physical condition based on their attributes.

NEC Patent Application for Estimation Device and System

The USPTO has published a patent application from NEC Corporation for an estimation device and system. The application, filed on December 3, 2025, describes a system that extracts feature amounts from gait waveforms to estimate a user's physical condition based on their attributes.

Patent Application for Adaptive Cognitive Training and Music Intervention

The USPTO has published a patent application (US20260088153A1) for adaptive cognitive training combined with music listening intervention. The application details methods for treating cognitive dysfunction by providing music and subsequently offering cognitive training games to users.

Medical Imaging Protocol Name Standardization System and Method

The USPTO has published a new patent application, US20260088154A1, detailing a system and method for standardizing medical imaging protocol names using machine learning. The application was filed on September 25, 2024, by inventors Philippe Gerner and Mathieu Bedez.

Patent Application for Tissue Section Image Processing

The USPTO has published a patent application (US20260088155A1) detailing a method and system for processing tissue section images. The application, filed on January 16, 2025, describes a process involving image acquisition, marker point identification, and image processing based on coordinate comparisons.

Medical Imaging Control Technique Based on Natural Language Request

The USPTO has published a patent application (US20260088156A1) from Siemens Healthineers AG detailing a technique for controlling medical imaging using natural language requests processed by large language models (LLMs). This application outlines a method for generating control signals for medical imaging preparation, execution, or processing based on user input.

Patent Application for Pathology Image Analysis Method

The USPTO has published a patent application (US20260088157A1) detailing a method for analyzing pathology image data. The invention focuses on identifying sets of image elements representative of sample properties using confidence scores and thresholds for pathology analysis.

Patent Application: Predicting Care Coordination Data Using EHR Machine Learning

The USPTO has published a patent application detailing a method for predicting care coordination data using EHR machine learning. The application, filed by Judith Payne and Jody Sheehan Garey, aims to improve scheduling and resource allocation by estimating patient acuity levels and care durations.

AI-Based Medical Patient Service System and Ecosystem Patent Application

The USPTO has published a patent application (US20260088162A1) for an AI-based medical patient service system. The system aims to manage patient requests, route them to appropriate personnel using AI, and includes features like financial incentives and gamification for staff.

Patent Application US20260088163A1: Simulated Peripheral Connections to Capital Equipment

The USPTO has published a new patent application, US20260088163A1, detailing a system for simulated peripheral connections to medical capital equipment. The application, filed on September 24, 2025, describes an adapter designed to authenticate peripheral devices by packaging their data in a format representative of a single-use device.

Automated Surgical Costing System with Staff Tracking

The USPTO has published a patent application (US20260088158A1) for an automated case costing system for surgical procedures. The system, assigned to Ospitek, Inc., tracks staff locations in real-time and analyzes staffing costs based on actual time spent in different areas of a surgery center.

Personalized Avatar Responsive to User State

The USPTO has published a patent application (US20260088164A1) for a system that provides personalized avatars responsive to a user's physiological state and context. The system uses biochemical information and biomarkers to adapt the avatar's appearance, potentially for guidance during programs or routines.

Ultrasound imaging remote access method patent application

The USPTO has published a patent application from SAMSUNG MEDISON CO., LTD. for a method of remotely accessing ultrasound imaging apparatus. The application details a process for activating and terminating remote access in sync with the start and end of an ultrasonic examination.

Client-Advisor Portal System Patent Application

The USPTO has published a patent application (US20260088166A1) filed by Vell LLC on September 22, 2025. The application describes systems and methods for active client monitoring by advisors, particularly in a healthcare context, involving sensor data, alerts, and rule modifications.

Cloud System for Optimizing Medical Study Transfer Imaging Workflows

The USPTO has published a patent application (US20260088167A1) detailing a cloud-based system designed to optimize the performance of imaging workflows for transferring medical studies. The system aims to improve the efficiency of study transfers to viewing applications.

Senior Living Engagement Platform Patent Application

The USPTO has published a patent application (US20260088168A1) for a senior living engagement and care support platform. The application, filed on December 3, 2025, describes a system designed to facilitate senior user engagement and provide updates to caregivers.

System and Method for Detection of Disease using Machine Learning

The USPTO has published a new patent application (US20260088169A1) detailing systems and methods for detecting systemic disease from bacterial samples using machine learning. The application, filed by inventors Mark Driscoll and Daniel Fasulo, focuses on correlating microbiome sequence data with disease states or risk.

Health Records Aggregation System with Body Map View

The USPTO has published a patent application for a health records aggregation system. The system collects health information from multiple sources, combines it into a database, and provides a view of the information on a body map. The patent application was filed on May 14, 2025.

Automatic configuration of user-specific data based on networked charger devices

The USPTO has published a patent application detailing techniques for automatically reconfiguring medical devices. This application describes methods for transferring user-specific configuration data from a second medical device to a first medical device when the first device is placed into service.

Patent Application for Patient-Specific Protein Interaction Graph

The USPTO has published a patent application (US20260088144A1) for a patient-specific protein-protein interaction graph system. This technology aims to improve clinical decision-making by analyzing patient mutational data and generating personalized interaction graphs for medical analysis tasks.

Healthcare Management System Patent Application Filed

The USPTO has published a patent application (US20260088145A1) for a healthcare management system. The application, filed on September 24, 2025, describes a computer system for analyzing medical reports using artificial intelligence and vectorized data embeddings to identify injury categories and severity.

Medical Virtual Assistant Patent Application

The USPTO has published a patent application (US20260088146A1) for a Medical Virtual Assistant. The application describes a method for processing patient treatment prompts using machine learning models to generate actionable recommendations.

System for Prescription Medication Discounting for Denied Coverage

The USPTO has published a patent application (US20260088147A1) for a system designed to provide seamless prescription medication discounts for services denied coverage by insurance plans, such as Medicare Part D. The system aims to automatically offer discounted costs to patients when their prescriptions are rejected by Pharmacy Benefit Managers.

AI-Based Radiomics Method for Predicting Disease Onset

The USPTO has published a patent application (US20260088170A1) detailing an AI-based radiomics method for predicting human disease onset using neural networks and color space analysis. The application, filed by Shubham Chandra, describes a non-invasive approach combining CNNs with CIELAB color space transformation for early disease detection and personalized diagnostics.

AGP Intelligent Interpretation and Insulin Adjustment Method

The USPTO has published a patent application from Northeastern University detailing an ambulatory glucose profile (AGP) intelligent interpretation and insulin adjustment method. This method utilizes an expert system to analyze patient data and provide decision support for basal and mealtime insulin adjustments.

Patent Application for Benzofuran Derivatives as SIK Inhibitors

The USPTO has published a patent application (US20260085053A1) from BEONE MEDICINES I GMBH for benzofuran derivatives that act as SIK inhibitors. These compounds are intended for the treatment of various inflammatory diseases.

Patent Application: Cancer Treatment Compositions and Methods

The USPTO has published a patent application (US20260085074A1) detailing compositions and methods for treating cancer by modulating K-Ras, a frequently mutated oncogene. The application was filed on June 17, 2025, by inventors Jonathan Ostrem, Ulf Peters, and Kevan M. Shokat.

Patent Application for Crystal Form of Aromatic Heterocyclic Compound

The USPTO has published a patent application (US20260085076A1) detailing a new crystal form (I and III) of an aromatic heterocyclic compound. The application also describes a production method and its use in treating diseases related to abnormal JAK-STAT signaling pathways.

Patent Application: Janus Kinase Inhibitors by Chiesi Farmaceutici

The USPTO has published a patent application (US20260085077A1) filed by Chiesi Farmaceutici S.P.A. The application describes compounds of general formula (I) that inhibit Janus Kinase (JAK) family kinases. These compounds are intended for therapeutic use in treating inflammatory diseases.

KDM1A Inhibitors for Disease Treatment Patent Application

The USPTO has published a new patent application (US20260085082A1) from Imago Biosciences, Inc. The application discloses new compounds and compositions for pharmaceutical use, specifically for inhibiting KDM1A and increasing gamma globin gene expression to treat diseases like acute myelogenous leukemia.

Chromophores with New Bridges that Increase Refractive Index

The USPTO has published a patent application (US20260085236A1) for Lightwave Logic, Inc., detailing new nonlinear optical (NLO) chromophores designed to increase refractive index. These chromophores offer improved electro-optic effects, modulation speed, photostability, and thermal stability, making them suitable for low-power, small-footprint electro-optic devices.

Patent Application for Artemisinic Acid Derivative Preparation

The USPTO has published a patent application (US20260085030A1) for an artemisinic acid derivative and its preparation method. The application, filed by Yunnan Botanee Bio-Technology Group Co., Ltd., aims to improve the water solubility of artemisinic acid and dihydroartemisinic acid while retaining their whitening, anti-inflammatory, and anti-tumor properties.

Patent Application for GYS1 Inhibitors

The USPTO has published a patent application (US20260085034A1) for N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE derivatives as inhibitors of Glycogen Synthase 1 (GYS1). The application details compounds and methods for preparing them, as well as methods for inhibiting GYS1 and treating GYS1-mediated diseases.

Patent Application for Psilocin Derivatives for Treating Disorders

The USPTO has published a patent application (US20260085040A1) for psilocin derivatives, including carbohydrate and amino acid conjugates. These compounds are intended for the treatment of various neuropsychiatric, neurodegenerative, neuroinflammatory, and pain disorders.

Patent Application: Organic Light Emitting Device Compound

The USPTO has published a new patent application, US20260090199A1, detailing a novel organic compound for use in organic light-emitting devices. The application describes a compound that may offer improved driving voltage, efficiency, and service life compared to existing technologies.

Patent for Heterocyclic Compound Organic Light Emitting Device

The USPTO has published a patent application for a heterocyclic compound intended for use in organic light-emitting devices. The application, filed by Eui-Jeong Choi and others, describes a compound that may improve device efficiency and lifespan.

Patent Application for NLO Chromophores with New Acceptors

The USPTO has published a patent application (US20260085190A1) filed by Lightwave Logic, Inc. The application describes nonlinear optical (NLO) chromophores designed to increase refractive index, offering advantages in speed, photostability, and thermal stability for electro-optic devices.

Patent Application for Chromophores with New Ring-Locked Donors

The USPTO has published a new patent application (US20260085189A1) filed by Lightwave Logic, Inc. The application describes novel nonlinear optical (NLO) chromophores with ring-locked donors designed to increase r33 and stability. The filing date was September 23, 2025.

Method for Preparing Indigo or Substituted Derivative

The USPTO has published a patent application (US20260085042A1) detailing a method for synthesizing indigo or substituted derivatives. The application, filed on June 16, 2023, describes a process involving anthranilic acid and glyoxylic acid under hydrogenation with a metal catalyst.

Patent Application: Initiator Mixture and Polymer Composition

The USPTO has published a new patent application (US20260085043A1) detailing an initiator mixture, a composition including it, and a polymer formed from the composition. The application was filed on September 18, 2025, by inventors from South Korea.

Patent Application for 4-Amino-5-Methyl Pyridin-2-One Production Process

The USPTO has published a patent application (US20260085044A1) detailing an improved process for producing 4-amino-5-methyl-(1H)-pyridin-2-one and its derivatives. The application, filed by MinAscent Technologies GmbH, describes a method using ammonium salts under pressure without gaseous ammonia, aiming for high yield and purity while reducing container corrosion.

Salts and Solid Forms of 4-hydroxy-N,N-diisopropyltryptamine

The USPTO has published a patent application detailing new salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DIPT), including hemi-glutarate and hemi-succinate forms. These forms are disclosed for their potential use in treating neurological and psychiatric disorders.

Patent Application for Nitrogen-Containing Heterocyclic Derivative Inhibitor

The USPTO has published a patent application (US20260085045A1) for a nitrogen-containing heterocyclic derivative inhibitor. The application details a compound, its preparation method, and its use in treating diseases such as cardiovascular and cerebrovascular conditions.

Patent Application: Dual Function Compounds for Cancer Treatment

The USPTO has published patent application US20260085046A1, filed on August 7, 2025, for dual function compounds intended for cancer treatment. The application discloses compounds of Formula (I) and their use in treating cancer.

Triphenylazole Compound Patent Application for Synucleinopathy Treatment

The USPTO has published a patent application (US20260085047A1) filed by Shiratori Pharmaceutical Co., Ltd. for a triphenylazole compound intended for the treatment or prevention of synucleinopathy. The application details the compound's structure and its potential use in pharmaceutical compositions.

ACSS2 Inhibitors for Cancer, Alcoholism, Viral Infections

The USPTO has published a patent application (US20260085048A1) detailing novel ACSS2 inhibitors and their potential uses in treating cancer, alcoholism, and viral infections. The application was filed on September 8, 2025.

Ergothioneine Crystal Form Patent Application

The USPTO has published a patent application (US20260085049A1) for a novel crystal form of ergothioneine and its preparation method. The application details a method for producing high-purity ergothioneine with low moisture content, intended for use in dietary supplements, foods, and cosmetics.

Triple Kinase Inhibitors for Cancer Treatment

The USPTO has published a patent application (US20260085050A1) for triple kinase inhibitor compounds designed for cancer treatment. The application details compounds that inhibit EGFR, ALK, and MET simultaneously, along with methods for treating cancer using these inhibitors.

Patent Application for 2-Chloro-4-Fluoro-5-Nitrobenzoic Acid Preparation

The USPTO has published a patent application (US20260085051A1) detailing a novel nitration process for preparing 2-chloro-4-fluoro-5-nitrobenzoic acid. The assignee is ADAMA AGAN LTD. This compound is used in the synthesis of the herbicide saflufenacil.

Patent Application for Furan Derivative Oxidation Process

The USPTO has published a patent application (US20260085052A1) detailing a new process for producing 2,5-furandicarboxylic acid. The application, filed by David Lee Sikkenga and Jan Hendrik Blank, describes a specific oxidation method involving furan derivatives, oxidants, solvents, and catalysts.

Hispidin Derivative Synthesis Method and Use

The USPTO has published a patent application (US20260085054A1) detailing a new method for synthesizing Hispidin derivatives and their use in preparing lipid-lowering drugs. The application describes a process using readily available starting materials with potential for large-scale industrial application.

Patent Application for Recyclable Polymer Material and Monomer

The USPTO has published a patent application (US20260085055A1) for a novel monomer and a chemically recyclable polymer material comprising the same. The application, filed by the Korea Institute of Science and Technology, describes a monomer formed by bonding a pentagonal cyclic olefin molecule with a photosensitive molecule to enable chemical recycling.

OX1 Receptor Antagonists Patent Application

The USPTO has published a new patent application (US20260085056A1) filed on May 9, 2025, by NXERA PHARMA UK LIMITED. The application relates to novel compounds for treating neurological or psychiatric disorders associated with orexin receptors.

Patent Application US20260085058A1 for SOS1 Degraders Treating Cancers

The USPTO has published patent application US20260085058A1, which relates to compounds that degrade son of sevenless homolog 1 (SOS1) and their use in treating cancers, particularly KRAS-mutant cancers. The application was filed on August 11, 2023.

System for updating medical facility uses AI

The USPTO has published a patent application for a system that uses AI to determine whether to update a medical facility. The system retrieves information from the facility, applies an AI model, and initiates maintenance or upgrades based on the determination. The application was filed on September 4, 2023.

Patent Application: Therapeutic Compounds - Orexin-1 Receptor Antagonists

The USPTO has published a new patent application (US20260085060A1) for therapeutic compounds that act as orexin-1 receptor antagonists. The application, filed on September 25, 2025, details compounds with structural formula (I), their preparation, and pharmaceutical uses.

Patent Application: Phthalazine Derivatives as Pyruvate Kinase Modulators

The USPTO has published a new patent application (US20260085061A1) for phthalazine derivatives as pyruvate kinase modulators, assigned to Sitryx Therapeutics Limited. The application was filed on September 25, 2025.

Novel compounds as CK2 inhibitors for disease treatment

The USPTO has published a patent application (US20260085062A1) for novel compounds identified as CK2 inhibitors. These compounds are intended for the treatment and prevention of various diseases, including cancer, viral infections, and neurodegenerative disorders. The application details specific chemical structures and their potential pharmaceutical uses.

Patent Application: Benzamide Compounds for SARS-CoV-2 PLpro Inhibition

The USPTO has published a new patent application (US20260085063A1) detailing benzamide compounds and methods for inhibiting SARS-CoV-2 PLpro. The application was filed on August 19, 2025, by inventors Jun Wang, Bin Tan, and Prakash Daulat Jadhav.

Patent Application: Benzofuranyl/Benzoxazolyl Compounds for Cancer Treatment

The USPTO has published a patent application (US20260085064A1) for substituted benzofuranyl and benzoxazolyl compounds, including their synthesis and use in treating cancer. The application was filed on May 2, 2025, by inventors from institutions including the University of Texas MD Anderson Cancer Center.

Patent for SGLT Inhibitor Synthesis Intermediate

The USPTO has published a patent application for a crystalline form of an intermediate useful in the synthesis of SGLT inhibitors. The application details a method to improve purification efficiency and minimize related substances in the final product, potentially increasing yield.

LRRK2 Degrading Compounds for Parkinson's Disease Treatment

The USPTO has published a new patent application (US20260085066A1) detailing bifunctional compounds designed to degrade LRRK2, a protein implicated in Parkinson's Disease. The application covers pharmaceutical compositions and methods for treating LRRK2-associated disorders.

Cyclic Sulfonamide RNR Inhibitors for Cancer Treatment

The USPTO has published a new patent application, US20260085067A1, detailing cyclic sulfonamide RNR inhibitors for cancer treatment. The application was filed on September 12, 2023, by inventors Anthony B. Pinkerton, Jacques Mauger, and Yen Pham Hong Truong.

Pritelivir Crystalline Form Patent Application

The USPTO has published a patent application (US20260085068A1) filed by Assembly Biosciences, Inc. on August 28, 2023. The application describes a novel crystalline form of the antiviral drug pritelivir, intended for the treatment of herpes virus.

USPTO Patent Application for Cancer Prodrugs

The USPTO has published a patent application (US20260085069A1) for novel prodrug compounds designed to treat cancer and other diseases by inhibiting Casein Kinase 2 alpha (CK2α). The application details specific chemical structures and their potential pharmaceutical uses.

Method for Preparing Intermediate of Adrenergic Receptor Agonist

The USPTO has published a patent application detailing a new method for preparing an intermediate of an adrenergic receptor agonist. The method claims to offer improved yield, reduced cost, and milder reaction conditions, making it more favorable for commercial production. The application was filed on December 4, 2025.

Patent Application for Pyrazolylcarboxamide Compounds for Therapy

The USPTO has published a patent application (US20260085073A1) for pyrazolylcarboxamide compounds and their use in therapy. The application details compounds that inhibit MALT1 and their potential treatment for proliferative, inflammatory, or autoimmune disorders.

Substituted Indazoles for Treating Animal Allergic Inflammatory Diseases

The USPTO has published a patent application detailing the use of substituted indazoles for the treatment and prevention of allergic and inflammatory diseases in animals. The application, filed on October 9, 2025, outlines specific compounds and their potential applications in veterinary medicine.

US Patent Application: Non-Aqueous Electrolyte, Battery, Device

The USPTO has published a new patent application (US20260088357A1) for a non-aqueous electrolyte, secondary battery, and electric device. The application, filed by CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED, details specific chemical compositions for electrolytes, including cyclic sulfate compounds and organic base additives. This publication represents a new disclosure in the field of battery technology.

Photoresist Molecular Group Structure, Synthesis, and Use Method

The USPTO has published a new patent application (US20260086460A1) for a bifunctional molecular group structure for photoresists, including a linker, PAG molecule, and PDQ molecule. The application also details synthesis and use methods for this structure, assigned to Shanghai Huali Integrated Circuit Corporation.

Psilocin Crystalline Forms Patent Application

The USPTO has published a patent application (US20260085039A1) detailing crystalline forms of psilocin, including salts and cocrystals. The application, filed by Jim Gilligan and Peter Guzzo, describes these forms as having improved physical properties like aqueous solubility and stability, suitable for various administration routes.

Novel Nootropic Prodrugs of Phenethylamine

The USPTO has published a patent application (US20260085036A1) for novel nootropic prodrugs of phenethylamine, assigned to MiHKAL GmbH. The application describes compounds designed to improve phenethylamine uptake and reduce side effects, potentially for treating conditions like depression and PTSD.

New Polymers and Methods Patent Application

The USPTO has published a new patent application, US20260085336A1, detailing processes for forming pyridinedicarboxylic acid derivatives and copolymers. The application, filed on September 25, 2025, outlines biocatalytic methods and potential uses for these new materials.

Patent Application for Novel Compound Treating Neurodegeneration and Cardiovascular Diseases

The USPTO has published a patent application (US20260085083A1) for a novel compound and pharmaceutical composition developed by SHANDONG RUZHI BIOMEDICINE TECHNOLOGY CO., LTD. The compound is intended for preventing or treating neurodegenerative diseases and cardiovascular/cerebrovascular diseases.

Protein Degraders Patent Application

The USPTO has published a new patent application, US20260085075A1, related to protein degraders and their uses. The application was filed on August 19, 2025, by inventors Nello Mainolfi, Nan Ji, Yi Zhang, and Matthew M. Weiss.

Patent Application for Novel Crystalline Form of Amine Compound

The USPTO has published a patent application (US20260085071A1) for novel crystalline forms of an amine compound, 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-N-methylazetidin-3-amine. The application also discloses pharmaceutical compositions and the use of these forms for treating diseases such as atopic dermatitis and urticaria.

Patent Application for Cancer Treatment Compounds

The USPTO has published a new patent application (US20260085070A1) for heterocyclic CBL-B inhibitors intended for the treatment of cancer. The application was filed on April 7, 2025, by inventors Yingzhi BI, Kenneth G. CARSON, and Geraldine Cirillo HARRIMAN.

Organic Compound and Light-Emitting Device Patent Application

The USPTO has published a patent application (US20260090268A1) for an organic compound and a light-emitting device incorporating it. The application details specific chemical structures and their application in electronic apparatus. The filing date was September 8, 2025.

Organic electronic element and compound for improved hole transport

The USPTO has published a new patent application, US20260090270A1, filed by TOSOH CORPORATION. The application describes an organic electronic element and a compound designed to improve hole transport ability, potentially enhancing performance in electronic devices.

Mitsubishi Gas Chemical Organic Thin Film Patent Application

The USPTO has published a new patent application from Mitsubishi Gas Chemical Company, Inc. for a compound and organic thin film technology. The application, filed on December 14, 2023, details a specific molecular structure intended for use in photoelectric conversion elements and imaging devices.

Insulin Dosing Function System Using Reinforcement Learning

The USPTO has published a patent application (US20260083909A1) detailing a system and method for calculating an insulin dosing function using reinforcement learning. The application describes a process that utilizes self-attention and a State-Action-Reward-Next State sequence to optimize insulin dosage decisions in automated medical systems.

Infusion Pump System Connectivity Site Tracking Patent Application

The USPTO has published a new patent application (US20260083911A1) detailing methods and systems for establishing communication protocols between wireless devices in infusion pump systems. The application focuses on coordinating communications among components like infusion pumps, CGM systems, and smartphones to ensure reliable medical data transmission.

Patent Application: Remote-Controlled Rotating Hand Mechanism in Aesthetic Medicine

The USPTO has published a new patent application (US20260083913A1) for a remote-controlled rotating hand mechanism designed for aesthetic medicine procedures. The application details a system incorporating multiple motors, ultrasound technology for safety monitoring, and a software platform for enhanced user experience and training.

Medicament Delivery Device Patent Application

The USPTO has published a new patent application, US20260083914A1, related to a medicament delivery device and its subassembly. The application was filed on August 29, 2023, by inventors Daniel Säll, Tai-Fu Wang, and Chun-Hsien Huang.

Autoinjector Patent Application Details Injection Device

The USPTO has published a new patent application, US20260083915A1, detailing an autoinjector for the automatic injection of medical products. The application was filed on August 11, 2023, and describes specific mechanical components and their interactions for drug delivery.

Drug Delivery Device Assembly Patent Application

The USPTO has published a new patent application, US20260083916A1, detailing an assembly for a drug delivery device. The application, filed on December 1, 2025, describes a novel cap mechanism for drug reservoirs that converts rotational user input into axial movement for release.

Auto injector with reconstitution handling support patent

The USPTO has published a new patent application, US20260083917A1, for an auto-injector with reconstitution handling support. The patent describes a device designed to mix medicament components within the auto-injector before administration, with a processing unit controlling the mixing process and providing an onset signal.

Tamper Resistant Syringe Assembly Patent Application

The USPTO has published a patent application (US20260083918A1) for a tamper-evident and tamper-resistant syringe assembly filed by Civica, Inc. The application describes devices and methods to prevent tampering with pre-filled syringes and provide evidence of attempted access.

USPTO Patent Application for Medicine Injecting Needle Module

The USPTO has published a new patent application (US20260083919A1) for a medicine injecting needle module filed by AGNES MEDICAL CO.,LTD. The application details a needle module designed for efficient medicine delivery.

Split-Luer Lock Connector Patent Application

The USPTO has published a new patent application, US20260083920A1, for a Split-Luer Lock Connector. The application, filed on September 8, 2025, describes a male Luer coupler designed to facilitate peripheral device coupling to a host device.

Patent Application for Hot Air Curing Adhesive Method

The USPTO has published a patent application (US20260083921A1) for a method of curing adhesive with hot air treatment during the assembly of glass syringes. The application, filed by ATS Corporation, details a process involving dispensing, arranging, radiation curing, and hot air heating steps.

USPTO Patent Application for Atomizing Body Assembly

The USPTO has published a patent application (US20260083922A1) for an atomizing body assembly and soft mist device with improved sealing performance. The application details an assembly including a T-shaped steel member, chip-mounting part, filter cartridge, and O-ring designed to enhance sealing. The filing date was October 31, 2022.

Capsule Inhaler for Phosphodiesterase-4 Inhibitor Patent Application

The USPTO has published a patent application (US20260083924A1) for a capsule inhaler device designed for administering a phosphodiesterase-4 inhibitor. The application, filed by Chiesi Farmaceutici S.P.A., details a drug product comprising a single-dose dry powder inhalation device and a pharmaceutical composition for treating respiratory diseases.

Patent Application for Variable Orifice Flow Shunt Devices

The USPTO has published a patent application (US20260083945A1) for variable orifice flow shunt devices designed to reduce peak systolic pressure. The application details devices with check valves and adjustable orifices for percutaneous shunting from the superior vena cava to the right pulmonary artery.

Patent Application for Implantable Sensors and Shunting Systems

The USPTO has published a new patent application (US20260083946A1) for implantable sensors and shunting systems. The application details a system for shunting blood between heart atria and includes a sensor with an actuation element to reduce tissue ingrowth. The filing date was December 3, 2025.

Capsule Inhaler Patent for Phosphodiesterase-4 Inhibitor

The USPTO has published a new patent application (US20260083711A1) for a capsule inhaler designed for administering phosphodiesterase-4 inhibitors. The patent, assigned to Chiesi Farmaceutici S.p.A., details a drug product comprising a single-dose dry powder inhalation device and a pharmaceutical composition for treating respiratory diseases.

Patent Application for Microstructure Array Delivering Active Agents

The USPTO has published a patent application (US20260083948A1) for a microstructure array designed for delivering active agents through the skin. The application details a formulation comprising dissolving microstructures attached to a base, intended for transdermal drug delivery.

Microneedle Patch and Manufacturing Method

The USPTO has published a new patent application, US20260083949A1, filed by Gachon University of Industry-Academic Cooperation Foundation. The application discloses a microneedle patch designed to protect active pharmaceutical ingredients from moisture and contaminants.

US Patent Application for Needle Locator and Guide

The USPTO has published a new patent application (US20260083950A1) for an apparatus designed to locate a target structure within a subject's body and guide a needle at a specific angle. The application was filed on September 1, 2023, by inventors Wim Bervoets, Daniel Smyth, Wolfram Frederik Dueck, and Jessica Brand.

Medical System and Liquid Circulation System for Brain Treatment

The USPTO has published a patent application (US20260083947A1) for a medical system and liquid circulation system designed for brain treatment. The system aims to efficiently deliver liquid to the brain while managing intracranial pressure fluctuations by controlling injection and discharge periods.

Implantable Medical Device Tubing Management Patent Application

The USPTO has published a new patent application (US20260083951A1) for an implantable medical device featuring a novel tubing management system. The application details a tube retainer designed to secure portions of the tubing connecting various components of the device.

Device for Delivering Antimicrobial Composition into Medical Device

The USPTO has published a patent application (US20260083952A1) for a device cap designed to deliver an antimicrobial composition into a medical device. The application details a male cap with a water-soluble antimicrobial composition, potentially covered by a slower-dissolving material to control dissolution during installation.

EPO Patent Bulletin: Medical Devices & Diagnostics

The European Patent Office's latest patent bulletin lists new publications and grants related to medical devices and diagnostics under the A61B classification. The bulletin includes details on inventions such as apparatus for forming bone canals, surgical microscope systems, and methods for imaging and biomarker detection, with publication dates in March 2026.

Powder Sprayer Patent Application

The USPTO has published a patent application (US20260084168A1) for a powder sprayer. The application details a device with specific air and powder inlets, a confluence channel, and an on-off valve system. The filing date was February 24, 2022.

USPTO Patent Application for Electrospraying Applicator Cartridges

The USPTO has published a new patent application (US20260084167A1) filed by Octet Medical, Inc. The application details disposable cartridges for electrospraying applicators, systems, and methods thereof. This represents a new intellectual property filing in the medical device sector.

New Mexico Measles Cases Rise to 15 Linked to Detention Centers

The New Mexico Department of Health reported that the state's measles case count has risen to 15, with all cases linked to federal detainees in three county detention centers. The department has deployed vaccination crews to these facilities to mitigate further spread.

WHO Accredited by Green Climate Fund for Climate and Health

The World Health Organization (WHO) has been accredited by the Green Climate Fund (GCF), enabling access to new funding for climate and health initiatives. This accreditation will support projects aimed at protecting communities from the health impacts of climate change, particularly in low- and middle-income countries.

WHO Report: 60+ Countries Include Refugees in Health Policies

The World Health Organization (WHO) released a report indicating that over 60 countries now include refugees and migrants in their national health policies. The report, based on data from 93 Member States, establishes a baseline for inclusive health systems but highlights remaining gaps in data collection, emergency preparedness, and culturally responsive care.

Dupilumab for Uncontrolled COPD with Raised Eosinophils

NICE has issued technology appraisal guidance TA1142 recommending dupilumab (Dupixent) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) and raised blood eosinophils. The guidance provides evidence-based recommendations for healthcare professionals.

Health Product InfoWatch: March 2026

Health Canada's March 2026 Health Product InfoWatch details recalls and safety updates for various medications, including Bicillin L-A, Bortezomib, Cefazolin, MAR-Amlodipine, and Seasonique/Seasonale. It also announces new market authorizations with conditions for Voxzogo and product monograph updates for Stivarga.

TGA Opens Consultation on Sunscreen Regulation Improvements

The Therapeutic Goods Administration (TGA) has opened an 8-week public consultation on proposed improvements to sunscreen regulation in Australia. The consultation seeks feedback on options to enhance SPF testing reliability, adopt new technologies, strengthen laboratory oversight, and improve labelling and quality assurance.

TGA Issues Infringement Notices for Unlawful Importation of Therapeutic Goods

The TGA has issued infringement notices totalling $23,760 to three health practitioners for allegedly importing unapproved therapeutic goods unlawfully. These goods, including unregistered botulinum toxin and hyaluronic acid, have not been assessed by the TGA and may pose health risks.

HHS and CMS Announce Healthcare Advisory Committee Members

HHS and CMS have announced the members of the new Healthcare Advisory Committee, a federal advisory body composed of healthcare leaders. The committee will provide non-binding recommendations to improve and modernize U.S. healthcare financing and delivery across Medicare, Medicaid, and other programs.

OIG Report: Part B Drug Payments Included Noncovered Self-Administered Versions, Increasing Costs

An HHS OIG report found that Medicare Part B payment amounts for the drug Omvoh included noncovered self-administered versions in 2024, increasing costs. Excluding these versions would have saved Part B and its enrollees an estimated $1,742 per vial in the fourth quarter of 2024. The report also noted that CMS's prior removal of noncovered self-administered versions for five other drugs saved $1.3 billion from 2023 through 2024.

USPTO Patent Application: Orally Disintegrating Corticosteroid Tablets for GI Inflammation

The USPTO has published a patent application (US20260083754A1) for orally disintegrating corticosteroid tablet compositions designed to treat gastrointestinal inflammation, specifically eosinophilic esophagitis. The application details the use of topically acting corticosteroids adsorbed onto a pharmaceutically acceptable carrier.

USPTO Patent Application: TYK2 Inhibitor Dosage Forms

The USPTO has published a patent application (US20260083733A1) for novel dosage forms of a TYK2 inhibitor, BMS-986165, intended for treating autoimmune diseases. The application details stable and bioavailable formulations, including spray-dried dispersions in a solid polymer matrix.

USPTO Patent Application for Metabolic Syndrome Treatment

The USPTO has published a patent application (US20260083753A1) for compositions and methods to treat metabolic syndrome. The application, filed by Kotha Sekharam, details improved compositions with enhanced solubility and bioavailability.

USPTO Patent Application: Cannabinoid Delivery Capsules

The USPTO has published a new patent application (US20260083756A1) from Fertin Pharma A/S for capsules designed for peroral cannabinoid delivery. The application details formulations using self-emulsifying drug delivery systems (SEDDS) with specific surfactant and cannabinoid content.

USPTO Patent Application for Tyk2 Inhibitor Dosage Forms

The USPTO has published a patent application (US20260083734A1) for novel dosage forms of Tyk2 inhibitors, specifically BMS-986165, intended for treating autoimmune and inflammatory diseases. The application details stable and bioavailable formulations, including spray-dried dispersions in a polymer matrix.

USPTO Patent Application for Self-Emulsifying Drug Delivery Systems

The USPTO has published a patent application from Fertin Pharma A/S for a dosage form utilizing self-emulsifying drug delivery systems (SEDDS) for cannabinoids. The application details specific formulations including surfactants with PEG moieties and isolated or synthetic cannabinoids.

USPTO Patent Application: Psychedelics Combined with NMDA Receptor Agonists

The USPTO has published a patent application (US20260083759A1) detailing combinations of psychedelic drugs with NMDA receptor agonists for treating neuropsychiatric and neurologic disorders. The application was filed on August 29, 2023, and is scheduled for publication on March 26, 2026.

Liquid Compositions Comprising Fiber for Prebiotic Dietary Supplements

The USPTO published patent application US20260083763A1 covering liquid compositions with therapeutic fiber ingredients designed as prebiotic dietary supplements to support gut microbiome health. Filed September 25, 2025, with application number 19339624, the application names five inventors and includes CPC classifications related to A61K therapeutic preparations. This publication provides public notice of the pending application and its technical specifications.

USPTO Patent Application for Tavapadon in Parkinson's Disease Treatment

The USPTO has published a patent application (US20260083740A1) detailing methods for treating Parkinson's Disease using escalating doses of tavapadon. The application was filed on September 23, 2025, by inventor Sridhar Duvvuri.

USPTO Patent Application for Photoprotective System

The USPTO has published a patent application (US20260083654A1) for a photoprotective system consisting of four specific sunscreens, assigned to PIERRE FABRE DERMO-COSMETIQUE. The application details a cosmetic or pharmaceutical composition with a photoprotective system representing 4% to 20% by weight.

USPTO Patent Application: Stable Liquid Bortezomib Formulations

The USPTO has published a patent application (US20260083760A1) for stable liquid bortezomib formulations filed by Riconpharma LLC. The application describes liquid compositions with specific impurity limits for intravenous or subcutaneous use.

USPTO Patent Application: Beta-1,3'-galactosyllactose for Gut Barrier Function Diseases

The USPTO has published a patent application (US20260083764A1) from N.V. Nutricia detailing the use of beta-1,3'-galactosyllactose for treating gut barrier function diseases, particularly in infants and young children. The application was filed on November 24, 2025.

USPTO Patent Application: Neuronal Migration Promoter for Brain Disease Treatment

The USPTO has published a patent application (US20260083761A1) from Public University Corporation Nagoya City University for a pharmaceutical composition and method to promote neuronal migration for treating brain diseases. The application details the use of a neuraminidase inhibitor.

USPTO Patent Application for NAD+ Concentration Support Compositions

The USPTO has published a patent application (US20260083765A1) for compositions and methods designed to support, optimize, and/or improve NAD+ concentrations in humans. The application details specific combinations of ingredients, including nicotinamide riboside, vitamins, and minerals.

USPTO Patent Application: Sialic Acid Compositions for Coronavirus Infections

The USPTO has published a patent application (US20260083762A1) detailing compositions comprising sialic acid for inhibiting or treating coronavirus infections, specifically those caused by SARS-CoV-2. The application was filed on August 18, 2025, by inventor Jan Remmereit.

USPTO Patent Application: Neurodegenerative Disorder Treatment

The USPTO has published a new patent application (US20260083766A1) detailing methods for treating neurodegenerative disorders by modulating RNA editing. The application was filed on May 16, 2025, by inventors Nandkishore Raghav Belur and Joseph Robert Mazzulli.

USPTO Patent Application: Solid Dosage Form of Antiviral Nucleoside

The USPTO has published a new patent application from Merck Sharp & Dohme LLC for an oral dosage form of a small molecule antiviral nucleoside. The application details specific formulation components and pellet size requirements for the antiviral drug.

USPTO Patent Application: Inflammasome Inhibition for Neuroprotection

The USPTO has published a new patent application detailing methods for treating retinal detachment using inflammasome inhibition. The application, filed by Jayakrishna Ambati, Peirong Huang, and Kameshwari Ambati, focuses on improving visual outcomes for patients with rhegmatogenous retinal detachment.

Testosterone Composition for Oral Delivery Treats Hypogonadism

The USPTO has published a patent application (US20260083755A1) assigned to NEUROCRINE UK LIMITED for a testosterone-containing pharmaceutical composition adapted for oral delivery. The application details treatment regimens and methods for hormone-related conditions like hypogonadism in human subjects.

USPTO Patent Application: RNA Complexes for Cancer Metastasis Treatment

The USPTO has published a new patent application detailing RNA complexes and nanostructures for cancer metastasis treatment. The application describes a one-step CMC production method for RNA therapeutic complexes containing nucleoside analogues, which self-assemble during RNA synthesis.

USPTO Patent Application: Method for Forming Drops Dispersion

The USPTO has published a patent application detailing a method for forming a dispersion with fatty and aqueous phases, including specific steps for creating and conveying fatty phase drops. This application, filed by inventors Duncan Gilbert and Mathieu Goutayer, outlines a novel approach to dispersion formation for potential use in various product formulations.

Patent Application: Cancer Treatment Methods and Compositions

The USPTO has published a patent application (US20260083752A1) for methods and compositions for treating cancer. The application, filed by the Regents of the University of Minnesota, involves the combination of p300/CBP modulators with senotherapeutics.

USPTO Patent Application: Allosteric Modulators for CRPC Therapy

The USPTO has published a patent application (US20260083751A1) from the University of Pittsburgh detailing allosteric modulators of the androgen receptor for treating castration-resistant prostate cancer (CRPC). The application describes small molecule compounds that may inhibit androgen receptor coactivator recruitment.

USPTO Patent Application: Dapiprazole for Eye Disorders

The USPTO has published a patent application (US20260083730A1) for a method of treating eye disorders using dapiprazole. The application, filed by Baradaina LLC, details a liquid composition for treating conditions such as presbyopia, glaucoma, or halos and glare.

USPTO Patent Application: Small Molecule Inhibitors of KRAS Proteins for Cancer Treatment

The USPTO has published a patent application (US20260083750A1) detailing small molecule inhibitors of KRAS proteins for cancer treatment. The application describes compounds that can inhibit specific KRAS protein mutants and their potential utility as therapeutic agents for cancer.

USPTO Patent for Anti-CD123 Immunoconjugates Treating AML

The USPTO has published a patent application (US20260083749A1) for anti-CD123 immunoconjugates, such as pivekimab sunirine, for treating acute myeloid leukemia (AML). The patent covers methods of use as monotherapies or in combination with other agents to achieve remission or prepare patients for transplant.

USPTO Patent Application: Compositions for Mitochondrial Health

The USPTO has published a patent application (US20260083747A1) detailing compositions for supporting mitochondrial health using methylthioninium salts combined with other compounds. The application was filed on October 30, 2024, by inventors Darren Lopez and Dan Schmidt.

USPTO Patent Application: Methods for Increasing Hematopoietic Stem Cells

The USPTO has published a patent application from Imago Biosciences, Inc. detailing methods for increasing hematopoietic stem cells and treating bone marrow failure using an LSD1 inhibitor. The application was filed on December 15, 2023, and published as US20260083729A1.

Reduced Dosing Regimens for Glaucoma Treatment Methods

The USPTO has published a patent application (US20260083746A1) detailing methods for treating open-angle glaucoma by transitioning patients to a once-daily dosing regimen. The proposed treatment involves a pharmaceutical composition containing timolol, brimonidine, dorzolamide, and bimatoprost.

USPTO Patent Application for Visual Pathway Strengthening Methods

The USPTO has published a new patent application (US20260083744A1) for methods of treating visual impairment by strengthening visual pathways. The application was filed on September 26, 2025, by inventors Ming-Fai Fong and Robert D. Lamprecht.

USPTO Patent Application: Compounds for Treating Parasitic Protozoa Infections

The USPTO has published a new patent application (US20260083728A1) detailing compounds for treating infections caused by parasitic protozoa, specifically Leishmania or Trypanosoma. The application was filed on September 18, 2023, by inventors from Karl WERBOVETZ et al.

USPTO Publishes Antiseptic Wipes Patent Application

The USPTO published a patent application for antiseptic wipes on March 26, 2026. The application details a cleansing composition including an antiseptic, humectant, emollient, surfactant, and monohydric alcohol, designed for use on a cloth. The invention also covers methods of preparing and packaging the wipes.

USPTO Patent Application: Nucleoside Derivative for Inflammation Treatment

The USPTO has published a patent application (US20260083743A1) detailing a nucleoside derivative for preventing and treating inflammation. The application, filed by WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY, claims the derivative offers better efficacy and fewer side effects than existing treatments like indometacin.

Patent Application for Cancer Treatment with Azenosertib and HRD Biomarker

The USPTO has published a patent application (US20260083742A1) detailing methods for treating cancer by administering azenosertib to subjects selected based on homologous recombination repair deficiency (HRD). The application was filed on December 1, 2025.

Sotorasib Dosing Regimen Patent Application

The USPTO has received a patent application (US20260083741A1) for a sotorasib dosing regimen. The application, filed by Brett E. Houk and Panli Cardona, details methods for administering sotorasib to patients, particularly those with KRAS G12C-mutated cancer who also require treatment with a BCRP substrate like rosuvastatin.

USPTO Patent Application: Dental Composition Production Method

The USPTO has published a patent application (US20260083644A1) detailing a method for producing dental polymerizable compositions or intermediates with improved storage stability. The method involves specific steps for disposing and operating a composition within a container to achieve high yield and stability.

USPTO Patent Application: Dietary Compositions for Health and Diabetes Treatment

The USPTO has published a patent application (US20260083739A1) for dietary compositions containing minerals and vitamins, intended for various health benefits including diabetes treatment, improved athletic performance, and immune support. The application was filed on December 2, 2025.

USPTO Patent Application: Modified Release Minoxidil for Hair Loss

The USPTO has published a patent application (US20260083738A1) detailing modified release minoxidil oral formulations for treating hair loss. The application, filed by Reid Waldman, describes compositions including minoxidil alone or with other active agents, and methods of treatment. This represents a new patent filing for a potential pharmaceutical product.

USPTO Patent Application: Method for Coloring Dental Ceramic

The USPTO has published a patent application detailing a method for coloring dental ceramic using a solution containing specific metal ions. The application, filed by inventors from Japan, describes a process involving contacting the dental ceramic with a coloring liquid where the difference between standard oxidation-reduction potentials of at least two metal ions is between 0.5 and 4.0.

USPTO Patent Application: Dental Composition with Stable Paste Properties

The USPTO has published a new patent application detailing a dental composition designed for stable paste properties. The invention focuses on a specific filler composition and its surface treatment to improve long-term storage stability for dental materials.

USPTO Patent Application: Modified Release Minoxidil Formulations

The USPTO has published a patent application (US20260083737A1) detailing modified release minoxidil oral formulations and methods for treating hair loss. The application describes pharmaceutical compositions containing minoxidil or its salts, potentially with other active agents, and includes methods for their administration and related kits.

USPTO Patent Application: GOAT Inhibitors for Substance Use Disorder

The USPTO has published a patent application (US20260083736A1) for ghrelin O-acyl transferase (GOAT) inhibitors intended for the treatment of substance use disorder, particularly in patients with high impulsivity. The application details compounds of general formula I and their use in treating opioid or stimulant use disorders.

USPTO Patent Application for ABHD6 Antagonist Drug

The USPTO has published a patent application filed by ONO Pharmaceutical Co., Ltd. for a novel ABHD6 antagonist drug. The application details a compound with potential therapeutic applications for diseases associated with ABHD6 activity.

Collagenase Compositions for Orthodontic Procedures Patent Application

The USPTO has published a patent application detailing compositions comprising collagenase and their uses in orthodontic procedures. The application, filed by inventors from Israel, describes potential uses for recombinant collagenase and modified forms thereof in dental treatments.

USPTO Patent Application: Topical Delivery Systems

The USPTO has published a new patent application (US20260083647A1) detailing topical delivery systems and multi-phase formulations. The application describes sustained-release barrier formulations designed for skin application, potentially offering time-dependent effects like hair follicle softening and delayed active ingredient delivery.

USPTO Patent Application: Deodorant Compositions

The USPTO has published a patent application (US20260083648A1) for deodorant compositions described by Dr. Squatch, LLC. The application details specific ingredient percentages for stick deodorants, emphasizing a high percentage of natural or naturally-derived ingredients.

USPTO Patent Application: Oral Care Composition with Mint Oil and Tin

The USPTO has published a new patent application (US20260083649A1) for an oral care composition. The invention involves a blend of mint oil, tin, and flavor extract designed to prevent the formation of methyl mercaptan, a compound that can cause unpleasant odors.

USPTO Patent Application: Oral Care Compositions

The USPTO has published a new patent application from Colgate-Palmolive Company for oral care compositions containing amino acids and flavor components. The application details methods of making and using these stabilized compositions, aiming to combine traditionally incompatible ingredients.

USPTO Patent Application for Skin Care Formulations

The USPTO has published a patent application (US20260083651A1) for skin care formulations. The application details a method of treating skin and a topical composition including various extracts and active ingredients. The filing date for this application was December 4, 2025.

USPTO Patent Application for Renewable Ester Emollient

The USPTO has published a patent application (US20260083652A1) for a renewable ester emollient for enhanced cutaneous permeation, assigned to Oxiteno S.A. Indústria e Comércio. The application details a personal care formulation and a method for moisturizing skin or hair using this emollient.

USPTO Patent Application: Tooth Whitening Preparation System

The USPTO has published a patent application (US20260083653A1) for a tooth whitening preparation system and method filed by Cobea AG. The application describes a component system including an active ingredient component and an activation component designed to adjust the pH for a physiologically acceptable tooth whitening preparation.

Uveal Melanoma Treatment Patent Application

The USPTO has published a patent application (US20260083731A1) detailing methods for treating uveal melanoma using a PKC inhibitor. The application, filed on August 25, 2023, by inventors Matthew Anthony Maurer, Michael Gabriel O'Quigley, and Julie Hambleton, focuses on neoadjuvant and/or adjuvant therapy to reduce metastasis and preserve eye function.

USPTO Patent Application: Upadacitinib Pharmaceutical Composition

The USPTO has published a new patent application (US20260083732A1) detailing a pharmaceutical composition for upadacitinib. The application, filed on September 6, 2023, describes a formulation involving upadacitinib, a hydrophobic release-controlling polymer, a pH modifier, and other excipients.

CMS Seeks Public Comment on Information Collection Activities

The Centers for Medicare & Medicaid Services (CMS) is seeking public comment on its intention to collect information from the public, as required by the Paperwork Reduction Act. This notice provides an opportunity for comment on the burden estimate and utility of proposed information collections related to Qualified Health Plan (QHP) certification and financial management.

USPTO Patent Application: Infusion Pump with Air Bubble Detection

The USPTO has published a patent application (US20260083903A1) for an infusion pump with an air bubble detection method. The invention utilizes an ultrasonic sensor and an imaging device to detect gas bubbles and particles in infusion fluids, aiming to enhance patient safety.

USPTO Patent Application for Infusion Tubing Sets

The USPTO has published a patent application for short-range communicating infusion tubing sets. The application describes a system where infusion tubing can transmit information to a pump, allowing the pump to verify compatibility with a prescribed medication regimen before dispensing.

USPTO Patent Application for Intravenous Needle Insertion Device

The USPTO has published a new patent application (US20260083907A1) for an intravenous needle insertion device. The application was filed by inventors Eric Gokcen and Cem Gokcen on September 19, 2023, and is scheduled for publication on March 26, 2026.

USPTO Patent Application: Thyroid Hormone Delivery Device

The USPTO has published a patent application (US20260083906A1) for a thyroid hormone delivery device. The application describes a subcutaneous implantable device with a microprocessor and precision pump for continuous thyroxine delivery, aiming to enhance patient compliance and metabolic control.

USPTO Publishes Medical Device Patent Application

The USPTO published a new patent application (US20260083905A1) for a medical device on March 26, 2026. The application, filed by Terumo Kabushiki Kaisha, describes a medical device with a housing, a flexible sheet-shaped adhesion member, and a detachable attachment.

USPTO Patent Application for Infusion Catheter Hub Assembly

The USPTO has published a new patent application for an infusion catheter hub assembly. The application details a system designed for delivering fluid and includes an introducer needle for inserting catheters or sensors, with a user-removable hub and an activation mechanism.

USPTO Patent Application: Syringe Actuator Coupling Device

The USPTO has published a new patent application (US20260083902A1) detailing a device for reversibly coupling a syringe to an actuator. The application was filed by inventors Jean-Luc MORELLE, Philippe DUMONT, and Philippe BEKAERT.

USPTO Patent for Negative Pressure Wound Therapy Canisters

The USPTO has published a new patent application, US20260083901A1, for negative pressure wound therapy canisters. The application details a canister design featuring two fluid chambers separated by a filter to manage fluids from a tissue site. This is a routine publication of a patent application.

USPTO Patent Application for Chemical Pump Housing

The USPTO has published a patent application for a chemical pump housing designed for negative pressure systems. The application details a housing with an inner chamber and a reactor configured to consume selected gases found in air, intended for use in negative pressure therapy.

USPTO Patent Application: Negative Pressure Wound Therapy Self-Testing

The USPTO has published a patent application (US20260083899A1) for a negative pressure wound therapy device with self-testing capabilities. The application details a system that includes a negative pressure source, valve, flow restrictor, pressure sensor, and control circuitry for performing leak, flow, or excessive pressure tests.

USPTO Patent Application for Aspiration Tubing Clip

The USPTO has published a patent application (US20260083305A1) for an aspiration tubing clip filed by Boston Scientific Scimed, Inc. The application describes a fluid system including a clamp for suction tubing used in medical devices.

USPTO Publishes Rectoscope Patent Application

The USPTO has published a new patent application, US20260083314A1, for a rectoscope designed for cavity inspection. The application, filed on May 29, 2025, details a device with a movable cover and a frangible window for controlled access.

USPTO Patent Application for Blood Draw Device Probe

The USPTO has published a new patent application, US20260083367A1, for a system designed to reduce buckling of a probe during the deployment of a blood draw device. The application details a fluid transfer device with specific components to control catheter movement and support.

USPTO Patent Application for Bipolar RF Access Device

The USPTO has published a patent application by Boston Scientific Scimed, Inc. for a bipolar RF access device with a sliding automatic shutoff cutting zone. The application details electrosurgical ablation devices designed for treating patient tissue.

USPTO Patent Application: Injection Apparatus and Method

The USPTO has published a patent application by pHi-Tech Animal Health Technologies Ltd. for an injection apparatus and method. The application details a hand-held unit, a remote control unit, and a pump designed for selecting medicament dose volumes.

USPTO Patent Application for Implantable Device Fixation for Urinary Incontinence

The USPTO has published a patent application (US20260083542A1) for an implantable device fixation mechanism designed to treat urinary incontinence. The application details a device with a conduit, an adjustable membrane for coaptation of a body lumen, and a fixation mechanism that can anchor or release the device using a push wire.

USPTO Patent Application for Stent Positioning Apparatus

The USPTO has published a patent application (US20260083580A1) for a stent positioning apparatus designed for use at the ostium of a blood vessel. The application details methods and apparatuses for precise stent placement, including an ostial positioning catheter with specific components.

USPTO Patent Application: Negative Pressure Wound Therapy Dressing System

The USPTO has published a patent application (US20260083596A1) for a negative pressure wound therapy (NPWT) dressing system. The application details a non-compressible, non-collapsible dressing with large-diameter passageways for suction and irrigation, designed for customizable and disposable use.

USPTO Patent Application: CBD for SYNGAP1 Encephalopathy

The USPTO has published a patent application (US20260083758A1) from Harmony Biosciences Management, Inc. detailing methods for treating SYNGAP1 encephalopathy using transdermal cannabidiol (CBD). The application was filed on November 28, 2025, and published on March 26, 2026.

USPTO Patent Application: System to Monitor Respiration During Sedation

The USPTO has published a patent application for a system designed to monitor patient respiration during sedation using nasal pressure and oxygen flow. The application details a method for identifying breathing patterns and delivering controlled oxygen pulses to ensure patient safety.

USPTO Patent Application: Gas Inhalation Mask

The USPTO has published a patent application for a gas inhalation mask with a paper body and tube attachment member, assigned to NIHON KOHDEN CORPORATION. The application details a design where the tube does not directly face the subject's face when attached.

Medical Gas Retention System Patent Application

The USPTO has published a patent application (US20260083929A1) for a medical gas retention system. The application, filed on September 15, 2025, describes a system designed to prevent unintended medical gas flow.

USPTO Patent Application: Water Quantity Detection in Humidifiers

The USPTO has published a patent application from ResMed Pty Ltd for methods and apparatus to determine the quantity of water in a humidifier. The application, filed on June 24, 2025, describes indirect measurement techniques using sensors to infer water levels without necessarily requiring disposable components.

USPTO Patent Application: Relaxation System

The USPTO has published a patent application (US20260083931A1) for a relaxation system. The system incorporates a vibrator, electrodes, and a feedback generator controlled by a processing device to monitor and influence cardiac metrics for relaxation status.

USPTO Patent Application: Odor-based TMR System

The USPTO has published a new patent application (US20260083932A1) for an odor-based TMR system designed to enhance learning and memory. The application, filed by Justin Dumitrescu, describes a system comprising a fragrance and a physical delivery system.

USPTO Patent Application: Relaxation System with Scent Release

The USPTO has published a patent application (US20260083933A1) for a relaxation system that includes a vibrator and a scent release mechanism. The application, filed by inventors Daniel Shuter, Angela Sun, and David Shuter, details a device controlled by a processing unit to manage both vibration and scent release.

USPTO Patent Application: Electronic Device for Sleep Induction Auditory Feedback

The USPTO has published a patent application (US20260083934A1) for an electronic device and method designed to provide auditory feedback for sleep induction based on a user's breathing patterns. The application details a system that synchronizes sounds with inhalation and exhalation periods.

Medical Device Reduces Friction Patent Application

The USPTO has published a patent application (US20260083940A1) for a medical device designed to reduce friction between contacting components by creating a lubricating barrier. The application was filed on September 17, 2025, by inventors Andrew James Schaubhut, Scott E. Brechbiel, and Ryan V. Wales.

USPTO Patent Application: Urinary Catheter Treatment

The USPTO has published a patent application (US20260083941A1) for a urinary catheter treatment involving a nitric oxide generating solution. The application details a method for mixing an S-nitrosothiol powder with a liquid carrier to create the solution, which is then introduced into a catheter balloon.

USPTO Patent Application: Non-occluding Balloon Catheter for Cardiovascular Drug Delivery

The USPTO has published a patent application for a non-occluding balloon catheter device designed for cardiovascular drug delivery. The application details a device that allows blood flow to continue through a bypass lumen while a drug coating is applied to the vessel wall. This innovation aims to improve drug delivery efficacy in cardiovascular treatments.

USPTO Patent Application for Clot Treatment Device

The USPTO has published patent application US20260083944A1 for a clot treatment system, including a balloon catheter with an inflation control device designed to reduce pressure during inflation. The application was filed on September 19, 2025, by inventors Benjamin Merritt and Jared Shimizu.

USPTO Patent Application: Medical Delivery System for Heart Valve

The USPTO has published a new patent application (US20260083446A1) for a medical delivery system designed for accessing and repairing a heart valve. The application was filed by Evalve, Inc. and details a system involving multiple steerable guide catheters.

USPTO Patent Application for Clot Aspiration and Blood Reinfusion Systems

The USPTO has published a patent application (US20260083467A1) for clot aspiration and blood reinfusion systems. The application details devices, systems, and methods for aspirating clot material and blood from a patient's vasculature, filtering the blood, and returning it. The filing date was September 19, 2025.

USPTO Patent Application: Shockwave Balloon Catheter and Control System

The USPTO has published a patent application for a four-interface shockwave balloon catheter and its control system. The invention aims to improve surgical treatment effectiveness and safety by allowing simultaneous fluid replenishment and discharge within the balloon. The application was filed on September 24, 2024.

Terumo Kabushiki Kaisha Catheter Patent Application

The USPTO has published a patent application (US20260083881A1) by Terumo Kabushiki Kaisha for a catheter designed to resist deterioration during long-term storage. The application details specific resin compositions and additive content for the catheter tip and main body.

USPTO Patent Application: Plasma Donation System

The USPTO has published a patent application detailing a system and method for individualized plasma donation. The invention aims to collect and determine plasma volume based on donor information and demographic data, adjusting collection protocols accordingly.

USPTO Patent Application: Negative-Pressure Accessory for Instrument

The USPTO has published a new patent application (US20260083886A1) for a negative-pressure accessory designed for use with negative-pressure instruments. The application details a device that includes a cup body and a pressure-sensing module to monitor negative pressure within the cup.

VA ECMO with Pulmonary Artery Ventilation Patent Application

The USPTO has published a patent application (US20260083887A1) for a Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) system with pulmonary artery ventilation. The application, filed by CardiacAssist, Inc., describes a dual lumen drainage cannula and associated system components designed to improve patient oxygenation and left ventricle unloading.

USPTO Patent Application: Air-Powered Peritoneal Dialysis System

The USPTO has published a new patent application (US20260083888A1) for an air-powered peritoneal dialysis system with nesting containers. The application details a system comprising a cycler with an air pump, a heater housing, nesting containers, and a control unit.

USPTO Patent Application: Damping Devices for Automated Peritoneal Dialysis Systems

The USPTO has published a new patent application detailing damping devices for automated peritoneal dialysis (APD) systems. The application, filed by inventors Farrukh Usman et al., describes a device with a body, first and second membranes, and a cavity designed to control fluid dynamics within APD systems.

USPTO Patent Application: Perfusion Pump with Occlusion Detection

The USPTO has published a patent application (US20260083890A1) for a perfusion pump with automatic occlusion detection and controlled adjustment. The application details a roller pump design incorporating sensors to measure pressure and adjust roller block movement to occlude a fluid conduit.

USPTO Patent Application: Aphaeretic Biopsy System with Microfluidic Device

The USPTO has published a new patent application, US20260083891A1, filed by Astrin Biosciences, Inc. The application describes an aphaeretic biopsy system utilizing a microfluidic device to separate and capture circulating tumor cells from a patient's bloodstream.

USPTO Patent Application: Vacuum Wound Dressing Connection Device

The USPTO has published a patent application (US20260083898A1) for a connection device designed to create a vacuum-tight fluidic connection between a vacuum wound dressing and a vacuum source. The application was filed by PAUL HARTMANN AG and includes specific structural features to prevent tube collapse under vacuum.

USPTO Patent Application: Postoperative Chest Drainage Device

The USPTO has published a new patent application (US20260083894A1) for a postoperative chest drainage device. The application details a device designed to collect fluids and separate gases originating from a patient's chest. This is a standard publication of a patent application, not a final grant or rule.

USPTO Patent Application for Surgical Suction Sponge

The USPTO has published a patent application (US20260083895A1) for a novel surgical suction sponge designed to improve the removal of bodily fluids during procedures. The application details devices, systems, and methods for a removable gasket and sponge assembly intended to protect delicate tissues while enhancing suction efficiency.

USPTO Ergonomical Medical Device Handle Fluid Coupling Patent Application

The USPTO has published a patent application (US20260083896A1) for an ergonomical medical device handle with a fluid coupling, designed for procedures like Transjugular Intrahepatic Portosystemic Shunt (TIPS). The application details a telescoping assembly with a shared flush port and locking features to improve device handling and control.

USPTO Patent Application: Body-Worn Therapeutic Speaker Device

The USPTO has published a new patent application for a body-worn therapeutic speaker device designed to deliver vibrational sound therapy. The application details a device that uses wireless speakers to promote circulation, muscle relaxation, and pain relief, while also incorporating mechanisms to minimize radiation exposure.

USPTO Patent Application for Aseptic Liquid Transfer Dispenser

The USPTO has published a patent application (US20260083637A1) for an aseptic liquid transfer dispenser system. The application details a drug delivery system designed for sterile transfer of liquid products, including a method for aseptically transferring drugs from a vial to the system.

USPTO Patent Application for Safe Surgical Suction Tip

The USPTO has published a patent application (US20260083475A1) for a new safe surgical suction tip designed to protect delicate tissues while effectively removing fluids. The application was filed by inventor Daniel R. Jacobson.

USPTO Patent Application: Cryo-ablation System for Sympathetic Nervous System Hyperactivity

The USPTO has published a patent application detailing a cryo-ablation system designed to treat sympathetic nervous system hyperactivity. The system utilizes a catheter with a configurable heat transfer element and deployable temperature probes to measure tissue temperature and optimize ablation.

USPTO Patent Application: Catheter with interlocking transition interface

The USPTO has published a new patent application, US20260083935A1, detailing a rapid exchange catheter with an interlocking transition interface. The application, filed on September 26, 2025, describes specific design features for improved catheter functionality and stability.

USPTO Patent Application for Locking Hub Systems

The USPTO has published a patent application for locking hub systems and related methods, filed by Christopher Cindrich. The application details a mechanism designed to align spanning distances and diminish gaps through rotational coupling of proximal and distal components.

USPTO Patent Application: Blood Pump with Reinforced Catheter

The USPTO has published a patent application (US20260083937A1) for a blood pump with a reinforced catheter, assigned to Abiomed Europe GmbH. The application details a catheter with a tubular stiffening structure designed to receive pressurized fluid.

USPTO Patent Application for Catheter Steering Device

The USPTO has published a new patent application, US20260083938A1, filed by Agile Devices, Inc. The application describes a novel system for steering catheters, designed to improve control and redirection within the body. This patent application is related to medical device technology.

USPTO Patent Application: Vascular Access Sheath

The USPTO has published a new patent application filed by Silk Road Medical, Inc. for a vascular access sheath system. The application details a system designed to limit insertion depth into an artery, with an adjustable exposed portion.

USPTO Patent Application: Catheter Assembly for Septoturbinatoplasty

The USPTO has published a new patent application (US20260083943A1) for a catheter assembly designed for septoturbinatoplasty procedures. The application details a device with a shaft and a primary balloon intended to realign nasal septums and treat turbinates.

USPTO Patent Application: Mucus Extraction Device

The USPTO has published a patent application for a mucus extraction device and method of use. The application describes a device with a compressible body for suction, a housing with a lighting member, and a grip for one-handed operation. The filing date was September 22, 2025.

USPTO Patent Application Filed for Air Extraction Device and Nasal Aspirator

The USPTO has published a new patent application (US20260083893A1) for an air extraction device and nasal aspirator filed by Zhongshan Xingfu Industry and Trade Co., Ltd. The application details a device designed to reduce air pressure within a cavity to create suction.

USPTO Patent Application: Negative Pressure Wound Therapy Dressing

The USPTO has published a patent application (US20260083897A1) for a dressing designed for negative pressure wound therapy. The application, assigned to PAUL HARTMANN AG, details a dressing with specific structural features to improve exudate distribution.

DEA: Mississippi Meth Dealer Sentenced to 10 Years

The DEA announced the sentencing of Anthony Russell, a Mississippi meth dealer, to 10 years in prison. This action is highlighted as a victory for public safety and the agency's mission to combat drug trafficking, particularly fentanyl.

USPTO Patent Application: Medicament Delivery Device Dosage Adjustment

The USPTO has published a patent application detailing a medicament delivery device that adjusts dosages based on a user's menstrual cycle phase. This technology aims to improve blood glucose control for users by reducing the risk of hyperglycemia and hypoglycemia.

USPTO Patent Application for Medical Testing and Treatment Protocols

The USPTO has published a patent application (US20260088141A1) for a system and method to determine medical testing and treatment protocols. The application, assigned to Intervention Insights, Inc., outlines a process for matching patient profiles to cohorts to identify appropriate tests and treatments.

USPTO Patent Application: Dementia with Lewy Bodies Identification Method

The USPTO has published a patent application detailing a method for identifying Dementia with Lewy Bodies (DLB) using DNA methylation patterns. The application, filed by inventors from Spain, describes a diagnostic technique involving mitochondrial DNA analysis and provides for classification models, oligonucleotides, and kits.

USPTO Patent Application for Continuous Patient Authentication

The USPTO has published a patent application (US20260087119A1) for systems and methods related to continuous patient authentication. The application describes techniques for passive authentication using sensor data to allow access to medical device software without user prompts.

USPTO Patent Application: Veterinary Orthopaedic Surgery Planning System

The USPTO has published a patent application (US20260083539A1) for a system and method for planning veterinary orthopaedic surgery. The application, filed by IN LIFE VET SA, describes a system for expanding bone implants to restore bone volume or geometry, utilizing a planning support with standardized fracture classifications.

Turf Toe Rehabilitation Device and Method Application

The USPTO has published a patent application for a turf toe rehabilitation device and method. The application details a device designed to assist patients in active and passive rehabilitation phases for metatarsophalangeal joint injuries, aiming to accelerate recovery.

USPTO Patent Application: Medical Ventilator Control Unit

The USPTO has published a new patent application (US20260083927A1) for a control unit for a medical ventilator. The application details a system designed to provide a respiratory air flow to a patient's respiratory apparatus.

USPTO Patent Application: Cordless Surgical Instrument Speed Limit

The USPTO has published a patent application from ConMed Corporation for a cordless surgical instrument designed to allow users to set and limit the maximum operating speed. This feature aims to enhance safety and precision during surgical procedures by enforcing a programmed speed limit.

USPTO Patent Application for Insulin Delivery Methods

The USPTO has published a patent application (US20260083910A1) detailing new methods, systems, and devices for insulin delivery. The application, filed on December 1, 2025, by inventors Bryan Mazlish and Lane Desborough, focuses on responsive basal insulin delivery rates and variable duration instructions for insulin delivery devices.

USPTO Patent Application: Radiation Dose Optimization for Particle Emitter

The USPTO has published a new patent application detailing a method for concurrent optimization of radiation doses for particle emitter devices across multiple treatment phases. The application, filed by Roni Hytonen, Perttu Niemelä, and Lauri Halko, aims to improve treatment efficacy by dynamically adjusting radiation doses based on phase-specific objectives.

USPTO Patent Application for Generating CD4 T Cells

The USPTO has published a patent application (US20260083778A1) for methods of generating CD4 T cells from progenitor cells. The application, assigned to Boston Medical Center Corporation, describes a specific differentiation process for therapeutic use.

USPTO Patent Application: CARs for Hidradenitis Suppurativa Treatment

The USPTO has published a patent application (US20260083777A1) filed by Sonoma Biotherapeutics, Inc. The application describes chimeric antigen receptors (CARs) designed to target citrullinated polypeptides for the treatment of hidradenitis suppurativa.

USPTO Patent Application: Cancer Treatment with Anti-CD20 Antibody and Acylfulvenes

The USPTO has published a patent application (US20260083691A1) filed by Lantern Pharma Inc. The application describes a method for treating cancer by combining an anti-CD20 antibody with acylfulvenes. This patent application is related to novel therapeutic combinations for B-cell cancers.

USPTO Patent Application: Thiazolidine Linkers for Protein-Drug Conjugates

The USPTO has published a new patent application (US20260083856A1) detailing thiazolidine linkers for protein-drug conjugates and their uses in treating diseases. The application was filed on September 11, 2025, and is scheduled for publication on March 26, 2026.

USPTO Patent Application: Anti-DPP3 Antibody Formulations

The USPTO has published a patent application from 4TEEN4 Pharmaceuticals GmbH for formulations and dosage amounts for administering an anti-DPP3 antibody or fragment thereof to humans. The application, filed on August 26, 2025, details potential treatments for life-threatening circulatory failure conditions such as shock.

USPTO Patent Application: Recombinant Human Type III Collagen for Angiogenesis

The USPTO has published a patent application (US20260083883A1) detailing recombinant human type III collagen designed to promote angiogenesis. The application describes modifications to natural type III collagen to enhance its angiogenic function and adhesion properties, potentially increasing the angiogenesis rate by over 37%.

USPTO Patent Application: Compositions Targeting Endothelial Cells

The USPTO has published a patent application from Harvard College detailing novel compositions for targeting endothelial cells. These compositions, which include binders, linkers, and radioactive isotopes, are intended for selective delivery to cells and treating diseases, including cancer.

USPTO Patent Application: Antibody Drug Conjugate Comprising NMT Inhibitor

The USPTO has published a new patent application (US20260083858A1) related to antibody drug conjugates (ADCs) that comprise an NMT inhibitor conjugated to an antibody via a linker. The application details the inventors and abstract of the invention.

USPTO Patent Application for Capsid Polypeptides

The USPTO has published a new patent application (US20260083863A1) from Dyno Therapeutics, Inc. for capsid polypeptides designed for payload delivery. The application details specific polypeptide sequences and their methods of use in therapeutic applications.

USPTO Patent Application for Immunoconjugates

The USPTO has published a new patent application, US20260083855A1, filed by Hoffmann-La Roche Inc. The application relates to immunoconjugates comprising a mutant interleukin-2 polypeptide and an antibody that binds to PD-1. This filing is part of the standard patent application process.

USPTO Patent Application: Antibody Conjugates with Bis-MSPT Linker

The USPTO has published a new patent application (US20260083854A1) detailing antibody conjugates that utilize a bis-MSPT linker. The application, filed by inventors Riazul Alam, Guillermo S. Cortez, and Yan Wang, describes pharmaceutical compositions and methods related to these conjugates.

USPTO Patent Application: CD70 Antibody Drug Conjugates

The USPTO has published a new patent application (US20260083853A1) detailing CD70 antibody drug conjugates for treating cancer and autoimmune diseases. The application was filed on October 25, 2023, by inventors Xiao Shang and others.

USPTO Patent Application for Peptoid Nucleic Acid Delivery

The USPTO has published a patent application (US20260083769A1) detailing novel hydroxyalkyl-capped cationic peptoids for nucleic acid delivery. The application, filed by inventors from various institutions, describes compositions and methods for delivering polyanionic compounds to cells and eliciting immune responses.

USPTO Patent Application: Sustained Transgene Expression of Modified ERT2 Peptide Fusion

The USPTO has published a patent application (US20260083859A1) detailing a novel fusion polypeptide for sustained transgene expression. The application, filed by inventors from various institutions, describes targeting constructs for inducible cell death systems using modified estrogen receptor ligand binding domains.

USPTO Patent Application for Anti-PD-1 Antibody-IL-2 Immunoconjugate Formulations

The USPTO has published a new patent application (US20260083857A1) for anti-PD-1 antibody-IL-2 immunoconjugate formulations. The application details stable pharmaceutical formulations comprising anti-human PD-1 antibody-modified human interleukin-2 immunoconjugates.

USPTO Patent Application: IL-17 Antibody Compositions

The USPTO has published a patent application (US20260083842A1) detailing pharmaceutical products and stable liquid compositions of IL-17 antibodies, such as secukinumab. The application covers methods of making these compositions and their use in treating IL-17-mediated disorders, including autoimmune conditions like psoriasis and rheumatoid arthritis.

Bispecific Molecule Stabilizing Composition Patent Application

The USPTO has published a patent application (US20260083841A1) for a pharmaceutical composition designed to stabilize bispecific antigen-binding molecules at increased concentrations. The composition includes buffer agents, saccharides, and specific stabilizing agents like EDTA or citric acid.

USPTO Patent Application: NEO-201 Antibody for Suppressing Myeloid Derived Suppressor Cells

The USPTO has published a patent application (US20260083840A1) detailing methods for ablating myeloid derived suppressor cells using the NEO-201 antibody. The application describes the antibody's specific binding to certain O-glycans and its potential use in treating cancers and infectious diseases by suppressing gMDSCs.

USPTO Patent Application: Treating NSCLC with Dostarlimab or Biosimilar

The USPTO has published a patent application detailing a method for treating non-small cell lung cancer (NSCLC) using dostarlimab or a biosimilar. The application outlines a treatment approach for patients previously treated with an immune checkpoint inhibitor.

USPTO Patent Application: Modified Coronavirus Spike Antigen Protein

The USPTO has published a patent application (US20260083836A1) for a modified coronavirus spike antigen protein. The application describes a protein designed to suppress cell membrane fusion ability and improve safety by modifying cleavage sites, aiming to enhance vaccine efficacy and antibody production.

USPTO Patent Application: Phage T4 Nanoparticle Vaccine Platform

The USPTO has published a patent application (US20260083835A1) detailing a modular bacteriophage T4 nanoparticle vaccine platform. This platform is designed for the rapid development of dual COVID-19 and flu mucosal vaccines, administered intranasally without an adjuvant.

USPTO Patent Application for CsgA-Derived Nanostructures for Antigen Delivery

The USPTO has published a patent application (US20260083834A1) for CsgA-derived nanostructures designed for antigen delivery. The application details self-assembling polypeptides conjugated to immunogens that form nanofilaments to stimulate immune responses, potentially for vaccines against various conditions.

USPTO Patent Application: Engineered Probiotics Expressing Anti-Inflammatory Molecules

The USPTO has published a patent application (US20260083783A1) from the University of Cincinnati for engineered probiotics that express anti-inflammatory molecules. The application details a genetically modified E. coli bacterium designed to produce a microbial anti-inflammatory molecule (MAM) protein.

Emergency Sirens Test Scheduled for April 7

The Delaware Division of Public Health announced a scheduled test of emergency sirens for Tuesday, April 7, 2026, at 7:20 PM. This test is part of the state's emergency preparedness measures, particularly concerning the Salem/Hope Creek Nuclear Generating Station.

VITADX Trademark Application Published

The United States Patent and Trademark Office (USPTO) has published the VITADX trademark application for opposition. The application covers pharmaceutical products, medical services, and software development and related services. The publication date is March 25, 2026.

ESN Elite Sports Nutrition Trademark Published for Opposition

The USPTO has published the trademark application for ESN Elite Sports Nutrition for opposition. The application covers a wide range of goods, including physical exercise equipment and various food and beverage products such as flavored milk, dairy spreads, and plant-based milk substitutes.

USPTO Trademark Application Published for Opposition: CARDIODYN

The USPTO has published the trademark application for 'CARDIODYN' for opposition. The application covers research and development services for medical devices, software for medical devices, and various implantable and extracorporeal heart support devices. The filing date was October 28, 2025.

NÆMOS Trademark Application Published for Opposition

The United States Patent and Trademark Office (USPTO) has published the trademark application for NÆMOS for opposition. The application covers a wide range of pharmaceutical products, medical supplies, and related chemical and nutraceutical preparations.

DINALYTIQS Trademark Publication for Opposition

The USPTO has published the DINALYTIQS trademark application for opposition, covering a range of medical, biomedical, and pharmaceutical services, as well as software for data processing and research. The publication opens a period for third parties to oppose the trademark registration.

MEDI Trademark Renewal

The United States Patent and Trademark Office (USPTO) has renewed the trademark application TM79114392 for the mark MEDI. The renewal is effective March 25, 2026. This renewal pertains to a broad range of goods and services, including medical services, prosthetics, and related materials.

USPTO Trademark Registration for DRYBAR

The USPTO has registered the trademark TM77982583 for DRYBAR, covering hair salon services. The registration was finalized on March 25, 2026, following a filing date of February 24, 2010.

USPTO Trademark Registration TM77944218: Hair Styling

The USPTO has registered trademark TM77944218 for "Hair styling" services, originally filed on February 24, 2010. The registration was finalized on March 25, 2026. This notice confirms the registration of the mark.

USPTO Trademark Application for VELOSEM

The USPTO has received an intent-to-use trademark application for the mark VELOSEM, filed on March 24, 2026. The application is related to plant breeding services.

New Moon Senior Living Trademark Application Published

The USPTO has published the trademark application for "New Moon Senior Living" for opposition. The application, filed on March 24, 2026, covers assisted living facility services, including residential care for the elderly, respite care, and palliative care support.

USPTO Trademark Application: Doctor Notes Software

The USPTO has received an intent-to-use trademark application for 'Doctor Notes,' a downloadable software application for recording, transcribing, and summarizing medical appointments. This application is intended for use by patients, caregivers, and healthcare providers.

USPTO Trademark Publication: ONCOTALK

The USPTO has published the trademark application for ONCOTALK for opposition. The application covers consulting services related to oncology diagnosis and treatment, aiming to connect healthcare professionals and facilitate discussions in the field. The publication date is March 25, 2026.

VITALSPACE Trademark Application for Downloadable Software and Health Services

The USPTO has received an intent-to-use trademark application for 'VITALSPACE' by an unnamed applicant. The application covers downloadable software for health screening and analysis, as well as health assessment and behavioral health services. The filing date was March 24, 2026, with an intended use date of March 25, 2026.

APEX MD Trademark Application - Medical Services

The USPTO has received a trademark application for 'APEX MD' covering a range of medical and pharmaceutical services. The application includes services related to weight management, hormone replacement therapy, and telehealth consultations.

USPTO Trademark Application: The Sugaring Hut (Intent to Use)

The USPTO has received an intent-to-use trademark application (TM99343580) for "The Sugaring Hut". The application covers a range of services including cosmetic hair removal, laser hair removal, beauty consultations, skincare treatments, and retail sales of beauty products.

USPTO Trademark Application - The Sugaring Hut

The USPTO has received an intent-to-use trademark application for 'The Sugaring Hut' (TM99343575). The application covers a range of services including cosmetic hair removal, personal hair removal, laser hair removal, beauty consultations, skincare treatments, and retail sales of beauty products.

USPTO Trademark Application - PAWSPITAL

The USPTO has received an intent-to-use trademark application for the mark PAWSPITAL. The application covers veterinary services and pet hospital services. The filing date was August 18, 2025.

WELLNIVERSE Intent to Use Trademark Application

The USPTO has published details for the WELLNIVERSE intent to use trademark application TM99341378, filed on March 24, 2026. The application covers a broad range of services including cryptocurrency staking, blockchain database hosting, smart contract programming, user authentication, digital collectibles (NFTs), virtual goods, augmented reality software, and various wellness and health services.

USPTO Intent to Use Trademark Application - School of Connection

The USPTO has received an intent to use trademark application (TM99339905) for 'School of Connection' filed on August 15, 2025. The application covers services including life coaching, mental health and wellness consulting, and providing related online information.

USPTO Trademark Application for TELEMENTIS - Medical Services

The USPTO has received an intent-to-use trademark application for the mark 'TELEMENTIS' for mental health services. The application was filed on August 15, 2025, and is designated as Kind: intent_to_use.

The Wholeness Code Trademark Application

The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for 'The Wholeness Code' filed on August 15, 2025. The application covers a broad range of services including bodywork therapy instruction, holistic health education, wellness coaching, and alternative medicine services.

USPTO Trademark Renewal - Dental Health Center

The USPTO has renewed trademark application TM99340337 for DENTAL HEALTH CENTER, which covers dental care services. The renewal is effective until March 24, 2026.

USPTO Trademark Application Intent to Use TM99342759

The USPTO has received an intent-to-use trademark application (TM99342759) for medical services related to cancer. The application covers a broad range of activities including research promotion, data management, charitable fundraising, and medical consulting.

USPTO Trademark Application - WHOLENESS ENERGY INSTITUTE

The USPTO has received an intent-to-use trademark application (TM99339562) from WHOLENESS ENERGY INSTITUTE for a wide range of services including bodywork therapy, energy healing, holistic health care, nutritional therapy, and educational services. The application was filed on March 24, 2026.

USPTO Trademark Application - Wholeness Energy Method

The USPTO has received an intent-to-use trademark application for "Wholeness Energy Method" filed on August 15, 2025. The application covers a broad range of services including bodywork therapy instruction, holistic health education, energy healing, professional coaching, and media production.

Apollo Surgery Center Trademark Renewal - Medical Services

The USPTO has renewed the trademark for Apollo Surgery Center for medical services, specifically vascular surgery. The renewal was processed on March 24, 2026, with an original filing date of August 15, 2025.

USPTO Trademark Application - WALK WITH US

The USPTO has received an intent-to-use trademark application for "WALK WITH US" filed on August 14, 2025. The application covers web-based mental health and wellness information services, social media content, and printed materials.

USPTO Trademark Application - Nabu's Bodywork & Sacred Healing

The USPTO has received an intent-to-use trademark application for 'Nabu's Bodywork & Sacred Healing'. The application covers services including massage therapy, Reiki healing, and holistic health services. The filing date was August 14, 2025.

Bear Necessities - Intent to Use Trademark Application

The USPTO has received an intent-to-use trademark application (TM99338301) from Bear Necessities for services including HVAC installation and maintenance, and landscape gardening. The application was filed on August 14, 2025.

USPTO Trademark Application - MBELEMED (Class 044)

The USPTO has received an intent-to-use trademark application for the mark MBELEMED, filed on August 14, 2025, and published on March 24, 2026. The application pertains to medical screening services related to the heart.

USPTO Trademark Application - One Red Step At A Time

The USPTO has received an intent-to-use trademark application for the mark "ONE RED STEP AT A TIME". The application covers goods such as bracelets, clothing, hats, socks, stickers, posters, and printed publications related to mental health and wellness, as well as services including providing mental health and wellness information via websites and social media.

USPTO Trademark Renewal: Caregiver Sanctuary

The United States Patent and Trademark Office (USPTO) has renewed the trademark 'Caregiver Sanctuary' (TM99337278) for medical services, including wellness programs and support for caregivers of individuals with dementia. The renewal is effective March 24, 2026.

GRACELY Trademark Application - Medical Services

The USPTO has received an intent-to-use trademark application for the mark "GRACELY" filed on August 14, 2025. The application covers a range of medical and nursing services, including memory care, respite care, and telehealth services.

YESRX.COM Intent to Use Trademark Application

The USPTO has received an Intent to Use trademark application (TM99336339) for the mark YESRX.COM, filed on August 13, 2025. The application seeks to cover telemedicine services. A future filing date of March 24, 2026, is noted for the application.

VIGGY USPTO Trademark Intent to Use Application

The USPTO has received an intent-to-use trademark application for the mark VIGGY, identified as TM99336194. The application covers printed publications, patient information services, medical information websites, and health information provision related to scientific, pharmaceutical, and medical topics, particularly central nervous system disorders. The filing date was August 13, 2025.

USPTO Trademark Application for CERV

The USPTO has received an intent-to-use trademark application for the mark 'CERV'. The application covers software as a service for enterprise resource planning and customer relationship management, as well as various services including lawn care, pest control, and property maintenance. The filing date was August 13, 2025.

STRIPIT Trademark Application - Medical Services

The USPTO has received an intent-to-use trademark application for the mark STRIPIT. The application covers services including a website featuring health and nutrition information, dietary and nutritional supplements, and online retail for wellness products. The filing date was August 14, 2025.

Breathíque Trademark Application - Intent to Use

The USPTO has received an intent-to-use trademark application for the mark "Breathíque" by an unspecified applicant. The application covers educational services, meditation training, meditation cushions, and wellness consulting.

USPTO Trademark Application - ONCOCONNECTS for Cancer Consulting

The USPTO has received an intent-to-use trademark application from ONCOCONNECTS for consulting services related to cancer diagnosis and treatment. The application was filed on August 13, 2025, and is designated for Class 044, which covers medical services.

Everwell Counseling Trademark Application Published for Opposition

The USPTO has published the trademark application for "Everwell Counseling and Consulting" for counseling services, including marriage, grief, and mental health counseling. The application was published for opposition on March 25, 2026, with a filing date of March 24, 2026.

USPTO Trademark Application - NO SHADE TAN CO

The USPTO has received an intent-to-use trademark application for the mark "NO SHADE TAN CO". The application covers a range of self-tanning and skin care products, as well as related services like online retail and spray tanning salons. The filing date for this application was March 24, 2026.

USPTO Trademark Application: Diabetes Reversal Alliance

The USPTO has received an intent-to-use trademark application for 'Diabetes Reversal Alliance' on March 24, 2026. The application covers various medical services, including diabetes treatment, telemedicine, wellness programs, and health information provision.

USPTO Trademark Application for Hair Care Products

The USPTO has received an intent-to-use trademark application for hair care products and related beauty consultation services. The application, filed on August 15, 2025, covers a range of hair care items including shampoos, conditioners, gels, sprays, serums, and emollients.

DEDICARE Trademark Application - Medical Services

The USPTO has received an intent-to-use trademark application for the mark DEDICARE. The application covers services including electronic health record management, telemedicine, medical billing support, and physician services. The filing date was August 15, 2025.

MYVAL TONE Trademark Application for AI Wellness Services

The USPTO has received an intent-to-use trademark application for 'MYVAGAL TONE' for AI wellness services, including software for stress measurement and health assessment, and wellness consulting. The application was filed on August 15, 2025.

USPTO Intent to Use Trademark Application - Rinse Dental

The USPTO has received an intent-to-use trademark application for 'Rinse Dental' filed on August 12, 2025. The application pertains to dentistry services and is identified by application number TM99333900.

USPTO Trademark Application for Cosmetic Services

The USPTO has received an intent-to-use trademark application for the mark TIIGRIS, filed on August 12, 2025. The application covers various cosmetic and medical camouflaging services. This filing indicates a potential new market entrant for these specialized services.

Revolution Medicines Trademark Renewal

The USPTO has renewed the trademark 'Revolution Medicines' (TM98222647) for pharmaceutical preparations and related services. The renewal is effective March 25, 2026, and covers services including drug discovery and providing medical information online.

DOVESONG RETREAT Trademark Application for Memory Care Services

The USPTO has received an intent-to-use trademark application for "DOVESONG RETREAT" for memory care and assisted living services. The application was filed on August 14, 2025, with an intended use date of March 24, 2026.

USPTO Trademark Application for REFRWORLD - Therapeutic Cold Therapy Packs

The USPTO has received an intent-to-use trademark application for the mark REFRWORLD, filed on August 10, 2025. The application covers a range of therapeutic cold and hot therapy products, including packs, wraps, and machines, as well as medical cooling apparatus.

NOVAMAG Dental Implants Trademark Application

The USPTO has received an intent-to-use trademark application for 'NOVAMAG' for artificial implants, specifically magnesium membranes for bone defects, intended for dental use. The application was filed on August 9, 2025, with an expected effective date of March 24, 2026.

CITOPRP Trademark Application for Medical Diagnostic Instruments

The USPTO has received an intent-to-use trademark application for the mark "CITOPRP" filed by an unnamed applicant. The application covers a range of medical diagnostic instruments, reagents, and preparations for medical and veterinary use.

GCS Trademark Application for Surgical Apparatus

The USPTO has received an intent-to-use trademark application from GCS for surgical apparatus and instruments. The application, filed on August 6, 2025, is designated under Class 010 for medical devices. This filing indicates a future intention to use the trademark in commerce.

Darkfin Labs - Intent to Use Trademark for Medical Biometric Monitors

The USPTO has received an intent-to-use trademark application from Darkfin Labs for "Darkfin Labs" and related goods. The application covers wearable monitors for measuring biometric data for medical use, as well as various supplements and skincare products. The filing date for this application was July 29, 2025.

USPTO Trademark Application for Diagnostic Kits and Medical Instruments

The USPTO has received an intent-to-use trademark application for "BOOMERANG KITS". The application covers diagnostic kits, reagents, assays, and medical diagnostic instruments for various health indicators. The filing date for this application was August 4, 2025.

USPTO Trademark Application: TEMA TOTAL ELBOW MODULAR ARTHROPLASTY

The USPTO has received an intent-to-use trademark application for 'TEMA TOTAL ELBOW MODULAR ARTHROPLASTY' filed on August 1, 2025. The application specifies elbow prostheses as the goods for which the trademark will be used.

USPTO Trademark Application - Priva Rotary Instruments

The USPTO has received an intent-to-use trademark application for 'Priva Rotary Instruments' for dental burs and polishers. The application was filed on July 31, 2025, with an intended use date of March 24, 2026.